<!DOCTYPE html><html lang="en" class="bg-surface-base antialiased"><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width, initial-scale=1, interactive-widget=resizes-content"/><link rel="stylesheet" href="/_next/static/css/62c4caba71dfda84.css" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/eb3d87f98fe1565f.css" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/1b5e561215938d4d.css" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/0227d069a630d414.css" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/f87fff2ab93d05a7.css" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4" data-precedence="next"/><link rel="preload" as="script" fetchPriority="low" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4" href="/_next/static/chunks/webpack-e121ed42680f327e.js"/><script src="/_next/static/chunks/78a669d9-e7993486b22c4915.js" async="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script><script src="/_next/static/chunks/40c4a5a7-abdabb07419d1cfc.js" async="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script><script src="/_next/static/chunks/2230-f7c87dc9fa57c408.js" async="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script><script src="/_next/static/chunks/main-app-536d4b8fca62396a.js" async="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script><script src="/_next/static/chunks/63f0ec43-8ee6a76d70472249.js" async="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script><script src="/_next/static/chunks/7670-7326298c9856172b.js" async="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script><script src="/_next/static/chunks/282-691fffb366e24ca5.js" async="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script><script src="/_next/static/chunks/7515-336759ef5dad2b52.js" async="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script><script src="/_next/static/chunks/927-34e2a6da3e15e26b.js" async="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script><script src="/_next/static/chunks/5855-243eeca8f0e4cabd.js" async="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script><script src="/_next/static/chunks/4393-1c8dff25ec904469.js" async="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script><script src="/_next/static/chunks/2225-454cf9f44775e7ce.js" async="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script><script src="/_next/static/chunks/7618-43536a8fb0dd3bfe.js" async="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js" async="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script><script src="/_next/static/chunks/7720-3a1e7e411adba2d3.js" async="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script><script src="/_next/static/chunks/7086-1f1c4891d766e04f.js" async="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/not-found-69a3edc7db5749d6.js" async="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script><script src="/_next/static/chunks/app/global-error-4d07d20223cd4b4c.js" async="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script><script src="/_next/static/chunks/8208b75a-a48e5a4507a0de91.js" async="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script><script src="/_next/static/chunks/5497-ab85ef3ea59dd353.js" async="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script><script src="/_next/static/chunks/6281-c6e84786dade3614.js" async="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script><script src="/_next/static/chunks/2660-d983a7f287e89f18.js" async="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script><script src="/_next/static/chunks/5002-9735c25beda556ba.js" async="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script><script src="/_next/static/chunks/3655-6717081f7512305a.js" async="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script><script src="/_next/static/chunks/8945-e4e3cf487f5e27c7.js" async="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script><script src="/_next/static/chunks/9214-a10614844a67ba31.js" async="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script><script src="/_next/static/chunks/4789-2080f6497f78b5b6.js" async="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script><script src="/_next/static/chunks/app/layout-226f2bd71acf9f9e.js" async="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script><script src="/_next/static/chunks/24cf1b50-159cca90b09285e0.js" async="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script><script src="/_next/static/chunks/9ffa21ba-c069766d809bd4c7.js" async="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script><script src="/_next/static/chunks/600-9a9fcafaaa6c1c4c.js" async="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script><script src="/_next/static/chunks/5448-2a3cfd853d899c9a.js" async="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script><script src="/_next/static/chunks/8-8ca70ca619d8e099.js" async="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js" async="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script><script src="/_next/static/chunks/app/error-4a29e9399afba038.js" async="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script><script src="/_next/static/chunks/app/not-found-dd95690acf732f18.js" async="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script><meta name="next-size-adjust" content=""/><title>Grokipedia</title><meta name="description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><link rel="icon" type="image/x-icon" href="/favicon.ico" sizes="48x48"/><link rel="icon" href="/images/icon-dark.png" media="(prefers-color-scheme: light)" type="image/png"/><link rel="icon" href="/images/icon-light.png" media="(prefers-color-scheme: dark)" type="image/png"/><link rel="apple-touch-icon" href="/icon-192x192.png"/><link rel="manifest" href="/manifest.webmanifest"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-snippet:-1"/><meta property="og:title" content="Grokipedia"/><meta property="og:description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><meta property="og:url" content="https://grokipedia.com"/><meta property="og:site_name" content="Grokipedia"/><meta property="og:locale" content="en_US"/><meta property="og:type" content="website"/><meta property="og:image" content="https://grokipedia.com/icon-512x512.png"/><meta property="og:image:width" content="512"/><meta property="og:image:height" content="512"/><meta property="og:image:alt" content="Grokipedia"/><meta name="twitter:card" content="summary"/><meta name="twitter:creator" content="@Grokipedia"/><meta name="twitter:title" content="Grokipedia"/><meta name="twitter:description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><meta name="twitter:image" content="https://grokipedia.com/icon-512x512.png"/><title>Carbamazepine</title><meta name="description" content="Carbamazepine , sold under the brand name Tegretol among others, is an anticonvulsant medication used in the treatment of epilepsy and neuropathic pain.[3][1] It is used as an adjunctive treatment in schizophrenia along with other medications and as a second-line agent in bipolar disorder.[1][15][16] Carbamazepine appears to work as well as phenytoin and valproate for focal and generalized seizures.6 It is not effective for absence or myoclonic seizures.[1] Carbamazepine was discovered in 1953..."/><meta name="author" content="system"/><link rel="manifest" href="/manifest.webmanifest"/><meta name="keywords" content="Tegretol, CBZ, Carbatrol, Equetro"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-snippet:-1"/><link rel="canonical" href="https://grokipedia.com/page/Carbamazepine"/><meta property="og:title" content="Carbamazepine"/><meta property="og:description" content="Carbamazepine , sold under the brand name Tegretol among others, is an anticonvulsant medication used in the treatment of epilepsy and neuropathic pain.[3][1] It is used as an adjunctive treatment in schizophrenia along with other medications and as a second-line agent in bipolar disorder.[1][15][16] Carbamazepine appears to work as well as phenytoin and valproate for focal and generalized seizures.6 It is not effective for absence or myoclonic seizures.[1] Carbamazepine was discovered in 1953..."/><meta property="og:url" content="https://grokipedia.com/page/Carbamazepine"/><meta property="og:site_name" content="Grokipedia"/><meta property="og:locale" content="en"/><meta property="og:image" content="https://grokipedia.com/icon-512x512.png"/><meta property="og:image:width" content="512"/><meta property="og:image:height" content="512"/><meta property="og:image:alt" content="Carbamazepine"/><meta property="og:type" content="article"/><meta property="article:modified_time" content="1970-01-21T09:19:13.239Z"/><meta name="twitter:card" content="summary"/><meta name="twitter:creator" content="@Grokipedia"/><meta name="twitter:title" content="Carbamazepine"/><meta name="twitter:description" content="Carbamazepine , sold under the brand name Tegretol among others, is an anticonvulsant medication used in the treatment of epilepsy and neuropathic pain.[3][1] It is used as an adjunctive treatment in schizophrenia along with other medications and as a second-line agent in bipolar disorder.[1][15][16] Carbamazepine appears to work as well as phenytoin and valproate for focal and generalized seizures.6 It is not effective for absence or myoclonic seizures.[1] Carbamazepine was discovered in 1953..."/><meta name="twitter:image" content="https://grokipedia.com/icon-512x512.png"/><link rel="icon" href="/favicon.ico" type="image/x-icon" sizes="16x16"/><meta name="sentry-trace" content="53d952fa4809151b513450954f807cad-31cf96a9a2fe4b04-1"/><meta name="baggage" content="sentry-environment=production,sentry-public_key=5f2258f71198ee26a355127af230c3a6,sentry-trace_id=53d952fa4809151b513450954f807cad,sentry-org_id=4508179396558848,sentry-transaction=GET%20%2Fpage%2F%5Bslug%5D,sentry-sampled=true,sentry-sample_rand=0.8406696065835382,sentry-sample_rate=1"/><script src="/_next/static/chunks/polyfills-42372ed130431b0a.js" noModule="" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4"></script></head><body class="flex h-[100svh] w-full flex-col __variable_13c637 __variable_8a0ba0 __variable_779740 __variable_2484fd __variable_525cc3 __variable_13486b"><div hidden=""><!--$--><!--/$--></div><script nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4">((a,b,c,d,e,f,g,h)=>{let i=document.documentElement,j=["light","dark"];function k(b){var c;(Array.isArray(a)?a:[a]).forEach(a=>{let c="class"===a,d=c&&f?e.map(a=>f[a]||a):e;c?(i.classList.remove(...d),i.classList.add(f&&f[b]?f[b]:b)):i.setAttribute(a,b)}),c=b,h&&j.includes(c)&&(i.style.colorScheme=c)}if(d)k(d);else try{let a=localStorage.getItem(b)||c,d=g&&"system"===a?window.matchMedia("(prefers-color-scheme: dark)").matches?"dark":"light":a;k(d)}catch(a){}})("class","theme","dark",null,["light","dark"],null,true,true)</script><header class="h-16 bg-surface-base fixed top-0 z-50 w-full"><div class="hidden h-full grid-cols-[1fr_3fr_1fr] items-center gap-4 !py-0 md:grid max-w-full py-6 px-4 w-full mx-auto"><div class="-ml-2 justify-self-start"><a class="cursor-pointer" href="/"><svg width="200" height="auto" viewBox="0 0 955 225" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M99.6937 159.214C90.008 159.214 81.5652 157.414 74.3652 153.814C67.1652 150.214 61.5509 144.986 57.5223 138.129C53.5794 131.271 51.608 123.043 51.608 113.443C51.608 103.843 53.5794 95.4857 57.5223 88.3714C61.5509 81.2572 67.1652 75.7286 74.3652 71.7857C81.6509 67.8429 90.1794 65.8714 99.9509 65.8714C103.208 65.8714 106.679 66.1286 110.365 66.6429C114.051 67.0714 117.222 67.6714 119.879 68.4429C121.508 68.8714 123.008 69.2572 124.379 69.6C125.751 69.9429 127.122 70.1143 128.494 70.1143C129.522 70.1143 130.551 69.9857 131.579 69.7286C131.751 73.5 131.922 77.4 132.094 81.4286C132.265 85.4572 132.522 89.6572 132.865 94.0286C131.065 94.2857 129.565 94.3714 128.365 94.2857C126.651 86.4 123.522 80.5714 118.979 76.8C114.437 72.9429 108.394 71.0143 100.851 71.0143C94.8509 71.0143 89.708 72.1286 85.4223 74.3572C81.2223 76.5 77.7937 79.4572 75.1366 83.2286C72.5652 87 70.6794 91.3714 69.4794 96.3429C68.2794 101.229 67.6794 106.457 67.6794 112.029C67.6794 120.171 68.9223 127.371 71.408 133.629C73.8937 139.886 77.6652 144.814 82.7223 148.414C87.8652 151.929 94.2937 153.686 102.008 153.686C104.408 153.686 107.065 153.471 109.979 153.043C112.894 152.529 115.679 151.757 118.337 150.729V134.529C118.337 131.871 118.208 129.814 117.951 128.357C117.779 126.814 117.222 125.7 116.279 125.014C115.422 124.329 114.008 123.857 112.037 123.6C110.151 123.257 107.537 122.957 104.194 122.7C103.937 121.329 103.937 119.957 104.194 118.586C105.994 118.586 108.179 118.629 110.751 118.714C113.322 118.714 115.894 118.757 118.465 118.843C121.122 118.843 123.308 118.843 125.022 118.843C127.679 118.843 130.722 118.8 134.151 118.714C137.665 118.629 140.665 118.586 143.151 118.586C143.322 119.871 143.322 121.2 143.151 122.571C139.637 123 137.108 123.429 135.565 123.857C134.022 124.286 133.079 125.143 132.737 126.429C132.394 127.714 132.222 129.9 132.222 132.986V137.1C132.222 141.129 132.308 144.514 132.479 147.257C132.737 150 132.951 151.971 133.122 153.171C121.208 157.2 110.065 159.214 99.6937 159.214ZM148.19 157.414C147.933 156.043 147.933 154.714 148.19 153.429C151.105 153.257 153.248 153 154.619 152.657C155.99 152.229 156.89 151.371 157.319 150.086C157.748 148.8 157.962 146.743 157.962 143.914V115.114C157.962 111.771 157.79 109.286 157.448 107.657C157.19 106.029 156.376 104.914 155.005 104.314C153.719 103.629 151.49 103.071 148.319 102.643C148.062 101.443 148.062 100.329 148.319 99.3C151.748 98.6143 155.09 97.8429 158.348 96.9857C161.605 96.0429 165.033 94.8429 168.633 93.3857L170.819 94.1572V105.471C176.819 97.8429 182.948 94.0286 189.205 94.0286C192.205 94.0286 194.433 94.8429 195.89 96.4714C197.348 98.0143 198.076 99.7714 198.076 101.743C198.076 104.057 197.305 105.857 195.762 107.143C194.219 108.343 192.462 108.943 190.49 108.943C188.862 108.943 187.233 108.514 185.605 107.657C184.062 106.8 182.905 105.471 182.133 103.671C179.219 103.671 176.605 104.829 174.29 107.143C172.062 109.371 170.948 111.986 170.948 114.986V142.629C170.948 145.971 171.119 148.371 171.462 149.829C171.89 151.286 172.919 152.229 174.548 152.657C176.262 153 179.005 153.257 182.776 153.429C182.948 154.629 182.948 155.957 182.776 157.414C179.862 157.414 176.862 157.371 173.776 157.286C170.69 157.2 167.519 157.157 164.262 157.157C161.09 157.157 158.262 157.2 155.776 157.286C153.376 157.371 150.848 157.414 148.19 157.414ZM229.285 158.829C223.028 158.829 217.542 157.5 212.828 154.843C208.199 152.1 204.599 148.371 202.028 143.657C199.457 138.857 198.171 133.371 198.171 127.2C198.171 120.514 199.499 114.686 202.157 109.714C204.899 104.743 208.714 100.886 213.599 98.1429C218.485 95.4 224.099 94.0286 230.442 94.0286C236.699 94.0286 242.142 95.4 246.771 98.1429C251.399 100.886 254.999 104.657 257.571 109.457C260.142 114.257 261.428 119.7 261.428 125.786C261.428 132.043 260.057 137.7 257.314 142.757C254.657 147.729 250.928 151.671 246.128 154.586C241.328 157.414 235.714 158.829 229.285 158.829ZM212.699 125.657C212.699 134.4 214.114 141.343 216.942 146.486C219.857 151.543 224.185 154.071 229.928 154.071C235.414 154.071 239.614 151.671 242.528 146.871C245.442 141.986 246.899 135.471 246.899 127.329C246.899 118.671 245.442 111.771 242.528 106.629C239.614 101.486 235.371 98.9143 229.799 98.9143C224.314 98.9143 220.071 101.271 217.071 105.986C214.157 110.7 212.699 117.257 212.699 125.657ZM267.394 157.414C267.308 157.071 267.265 156.729 267.265 156.386C267.265 156.043 267.265 155.7 267.265 155.357C267.265 155.014 267.265 154.714 267.265 154.457C267.265 154.114 267.308 153.771 267.394 153.429C270.308 153.257 272.451 153 273.822 152.657C275.194 152.229 276.094 151.371 276.522 150.086C276.951 148.8 277.165 146.743 277.165 143.914V79.5C277.165 76.8429 276.908 74.8714 276.394 73.5857C275.965 72.2143 274.979 71.2714 273.437 70.7572C271.979 70.1572 269.751 69.7286 266.751 69.4714C266.665 69.1286 266.622 68.8286 266.622 68.5714C266.622 68.3143 266.622 68.0572 266.622 67.8C266.622 67.4572 266.622 67.1572 266.622 66.9C266.622 66.6429 266.665 66.3429 266.751 66C270.179 65.5714 273.694 64.9286 277.294 64.0714C280.894 63.1286 284.579 61.8429 288.351 60.2143L290.537 60.9857C290.451 62.8714 290.365 65.0143 290.279 67.4143C290.279 69.8143 290.279 72.4286 290.279 75.2572V122.957C291.308 122.957 292.165 122.786 292.851 122.443C293.537 122.1 294.094 121.757 294.522 121.414C294.694 121.243 295.037 120.943 295.551 120.514C296.065 120 296.965 119.1 298.251 117.814C299.537 116.529 301.379 114.6 303.779 112.029C306.008 109.543 307.765 107.614 309.051 106.243C310.422 104.786 311.108 103.586 311.108 102.643C311.108 101.957 310.508 101.4 309.308 100.971C308.194 100.457 306.651 100.157 304.679 100.071C304.594 99.7286 304.551 99.3857 304.551 99.0429C304.551 98.7 304.551 98.3572 304.551 98.0143C304.551 97.6714 304.551 97.3286 304.551 96.9857C304.551 96.6429 304.594 96.3 304.679 95.9572C306.394 95.9572 308.537 96 311.108 96.0857C313.765 96.1714 316.122 96.2143 318.179 96.2143C319.208 96.2143 320.665 96.2143 322.551 96.2143C324.522 96.1286 326.494 96.0857 328.465 96.0857C330.437 96.0857 331.894 96.0857 332.837 96.0857C332.922 96.4286 332.965 96.7714 332.965 97.1143C333.051 97.4572 333.094 97.8 333.094 98.1429C333.094 98.4857 333.051 98.8286 332.965 99.1714C332.965 99.4286 332.922 99.7286 332.837 100.071C328.379 100.157 324.608 101.271 321.522 103.414C318.437 105.471 315.479 107.914 312.651 110.743L303.394 120L321.137 143.4C323.022 145.886 324.565 147.857 325.765 149.314C327.051 150.686 328.422 151.671 329.879 152.271C331.337 152.871 333.351 153.257 335.922 153.429C336.094 154.629 336.094 155.957 335.922 157.414C334.808 157.414 333.137 157.371 330.908 157.286C328.765 157.2 325.379 157.157 320.751 157.157C320.065 157.157 319.037 157.157 317.665 157.157C316.294 157.157 315.008 157.243 313.808 157.414C313.808 156.471 313.294 155.186 312.265 153.557C311.237 151.843 310.422 150.6 309.822 149.829C309.565 149.4 308.922 148.5 307.894 147.129C306.865 145.671 305.622 144 304.165 142.114C302.794 140.143 301.379 138.171 299.922 136.2C298.465 134.143 297.137 132.343 295.937 130.8C294.994 129.514 294.094 128.529 293.237 127.843C292.465 127.071 291.479 126.686 290.279 126.686V142.629C290.279 145.971 290.408 148.371 290.665 149.829C291.008 151.286 291.737 152.229 292.851 152.657C294.051 153 295.851 153.257 298.251 153.429C298.422 154.714 298.422 156.043 298.251 157.414C296.022 157.414 293.665 157.371 291.179 157.286C288.779 157.2 286.165 157.157 283.337 157.157C280.594 157.157 277.894 157.2 275.237 157.286C272.579 157.371 269.965 157.414 267.394 157.414ZM369.34 157.414C366.94 157.414 364.454 157.371 361.883 157.286C359.311 157.2 356.526 157.157 353.526 157.157C350.783 157.157 347.997 157.2 345.169 157.286C342.426 157.371 339.769 157.414 337.197 157.414C336.94 156.043 336.94 154.714 337.197 153.429C340.111 153.257 342.254 153 343.626 152.657C344.997 152.229 345.897 151.371 346.326 150.086C346.754 148.8 346.969 146.743 346.969 143.914V115.114C346.969 111.771 346.84 109.286 346.583 107.657C346.326 106.029 345.511 104.914 344.14 104.314C342.854 103.629 340.583 103.071 337.326 102.643C337.069 101.443 337.069 100.329 337.326 99.3C341.097 98.6143 344.697 97.7572 348.126 96.7286C351.554 95.7 354.854 94.5857 358.026 93.3857L360.211 94.1572C360.126 96.8143 360.04 99.3 359.954 101.614C359.954 103.929 359.954 106.114 359.954 108.171V142.629C359.954 145.971 360.126 148.371 360.469 149.829C360.897 151.286 361.754 152.229 363.04 152.657C364.411 153 366.511 153.257 369.34 153.429C369.597 154.714 369.597 156.043 369.34 157.414ZM343.626 71.5286C343.626 69.0429 344.483 66.9429 346.197 65.2286C347.997 63.5143 350.14 62.6572 352.626 62.6572C355.026 62.6572 357.083 63.5143 358.797 65.2286C360.597 66.9429 361.497 69 361.497 71.4C361.497 73.6286 360.64 75.6857 358.926 77.5715C357.211 79.3714 355.026 80.2714 352.369 80.2714C349.969 80.2714 347.911 79.4143 346.197 77.7C344.483 75.9857 343.626 73.9286 343.626 71.5286ZM372.678 188.914C372.592 187.543 372.592 186.214 372.678 184.929C375.678 184.757 377.864 184.457 379.235 184.029C380.607 183.6 381.464 182.743 381.807 181.457C382.235 180.257 382.45 178.286 382.45 175.543V115.114C382.45 111.771 382.278 109.286 381.935 107.657C381.678 106.029 380.864 104.914 379.492 104.314C378.207 103.629 375.978 103.071 372.807 102.643C372.635 101.443 372.635 100.329 372.807 99.3C376.321 98.6143 379.75 97.8 383.092 96.8572C386.435 95.9143 389.907 94.7572 393.507 93.3857L395.307 94.2857C395.221 96.4286 395.178 98.2714 395.178 99.8143C395.178 101.271 395.178 102.686 395.178 104.057C398.521 100.543 401.821 98.0143 405.078 96.4714C408.335 94.8429 411.807 94.0286 415.492 94.0286C420.892 94.0286 425.435 95.4429 429.121 98.2714C432.892 101.1 435.764 104.786 437.735 109.329C439.707 113.871 440.692 118.8 440.692 124.114C440.692 130.371 439.321 136.157 436.578 141.471C433.921 146.7 430.192 150.9 425.392 154.071C420.592 157.243 415.021 158.829 408.678 158.829C406.192 158.829 403.835 158.614 401.607 158.186C399.378 157.843 397.278 157.329 395.307 156.643V174C395.307 177.343 395.564 179.743 396.078 181.2C396.592 182.657 397.707 183.557 399.421 183.9C401.135 184.329 403.835 184.629 407.521 184.8C407.607 186.171 407.607 187.543 407.521 188.914C404.607 188.914 401.65 188.871 398.65 188.786C395.735 188.7 392.521 188.657 389.007 188.657C385.664 188.657 382.792 188.7 380.392 188.786C377.992 188.871 375.421 188.914 372.678 188.914ZM395.178 146.1C398.864 151.414 403.75 154.071 409.835 154.071C414.121 154.071 417.507 152.871 419.992 150.471C422.564 148.071 424.407 144.943 425.521 141.086C426.721 137.229 427.321 133.157 427.321 128.871C427.321 124.586 426.764 120.386 425.65 116.271C424.535 112.157 422.692 108.771 420.121 106.114C417.635 103.371 414.207 102 409.835 102C404.607 102 399.721 104.529 395.178 109.586V146.1ZM477.335 158.829C471.25 158.829 466.107 157.414 461.907 154.586C457.707 151.757 454.493 147.986 452.264 143.271C450.121 138.471 449.05 133.2 449.05 127.457C449.05 121.543 450.164 116.057 452.393 111C454.707 105.943 458.05 101.871 462.421 98.7857C466.793 95.6143 472.107 94.0286 478.364 94.0286C485.907 94.0286 491.778 96.3 495.978 100.843C500.264 105.3 502.407 111.086 502.407 118.2C502.407 119.057 502.364 119.829 502.278 120.514C502.278 121.114 502.235 121.629 502.15 122.057L461.65 121.671C461.65 122.014 461.65 122.314 461.65 122.571C461.65 130.971 463.578 137.571 467.435 142.371C471.293 147.171 476.693 149.571 483.635 149.571C489.464 149.571 495.207 147.686 500.864 143.914C501.721 144.943 502.364 145.929 502.793 146.871C495.507 154.843 487.021 158.829 477.335 158.829ZM462.035 116.914L488.65 116.4C488.735 116.229 488.778 116.014 488.778 115.757C488.778 115.414 488.778 115.2 488.778 115.114C488.778 110.486 487.75 106.629 485.693 103.543C483.721 100.457 480.764 98.9143 476.821 98.9143C473.135 98.9143 469.921 100.414 467.178 103.414C464.435 106.414 462.721 110.914 462.035 116.914ZM559.644 158.957L557.587 158.057L557.073 149.186C554.073 152.443 550.987 154.886 547.816 156.514C544.73 158.057 541.302 158.829 537.53 158.829C532.216 158.829 527.544 157.414 523.516 154.586C519.573 151.671 516.53 147.9 514.387 143.271C512.244 138.643 511.173 133.629 511.173 128.229C511.173 121.971 512.502 116.271 515.159 111.129C517.902 105.986 521.716 101.871 526.602 98.7857C531.573 95.6143 537.359 94.0286 543.959 94.0286C545.93 94.0286 547.987 94.2 550.13 94.5429C552.273 94.8 554.502 95.2714 556.816 95.9572V79.5C556.816 76.8429 556.559 74.8714 556.044 73.5857C555.53 72.2143 554.502 71.2714 552.959 70.7572C551.502 70.1572 549.273 69.7286 546.273 69.4714C546.016 68.3572 546.016 67.2 546.273 66C549.702 65.5714 553.216 64.9286 556.816 64.0714C560.416 63.1286 564.102 61.8429 567.873 60.2143L570.059 60.9857C569.973 62.8714 569.887 65.0143 569.802 67.4143C569.802 69.8143 569.802 72.4286 569.802 75.2572V139.029C569.802 142.286 569.93 144.729 570.187 146.357C570.445 147.986 571.216 149.143 572.502 149.829C573.787 150.429 575.973 150.986 579.059 151.5C579.316 152.614 579.316 153.771 579.059 154.971C575.63 155.486 572.287 156.043 569.03 156.643C565.773 157.243 562.644 158.014 559.644 158.957ZM556.944 106.886C553.259 101.829 548.416 99.3 542.416 99.3C536.502 99.3 532.044 101.486 529.044 105.857C526.044 110.143 524.544 116.1 524.544 123.729C524.544 128.186 525.144 132.471 526.344 136.586C527.544 140.7 529.516 144.086 532.259 146.743C535.002 149.4 538.644 150.729 543.187 150.729C548.93 150.729 553.516 148.243 556.944 143.271V106.886ZM615.699 157.414C613.299 157.414 610.813 157.371 608.242 157.286C605.67 157.2 602.885 157.157 599.885 157.157C597.142 157.157 594.356 157.2 591.527 157.286C588.785 157.371 586.127 157.414 583.556 157.414C583.299 156.043 583.299 154.714 583.556 153.429C586.47 153.257 588.613 153 589.985 152.657C591.356 152.229 592.256 151.371 592.685 150.086C593.113 148.8 593.327 146.743 593.327 143.914V115.114C593.327 111.771 593.199 109.286 592.942 107.657C592.685 106.029 591.87 104.914 590.499 104.314C589.213 103.629 586.942 103.071 583.685 102.643C583.427 101.443 583.427 100.329 583.685 99.3C587.456 98.6143 591.056 97.7572 594.485 96.7286C597.913 95.7 601.213 94.5857 604.385 93.3857L606.57 94.1572C606.485 96.8143 606.399 99.3 606.313 101.614C606.313 103.929 606.313 106.114 606.313 108.171V142.629C606.313 145.971 606.485 148.371 606.827 149.829C607.256 151.286 608.113 152.229 609.399 152.657C610.77 153 612.87 153.257 615.699 153.429C615.956 154.714 615.956 156.043 615.699 157.414ZM589.985 71.5286C589.985 69.0429 590.842 66.9429 592.556 65.2286C594.356 63.5143 596.499 62.6572 598.985 62.6572C601.385 62.6572 603.442 63.5143 605.156 65.2286C606.956 66.9429 607.856 69 607.856 71.4C607.856 73.6286 606.999 75.6857 605.285 77.5715C603.57 79.3714 601.385 80.2714 598.727 80.2714C596.327 80.2714 594.27 79.4143 592.556 77.7C590.842 75.9857 589.985 73.9286 589.985 71.5286ZM665.837 158.571C660.18 158.571 656.623 155.743 655.165 150.086C649.08 155.914 642.865 158.829 636.523 158.829C632.151 158.829 628.423 157.543 625.337 154.971C622.337 152.314 620.837 148.671 620.837 144.043C620.837 132.729 632.365 125.614 655.423 122.7C655.423 120.643 655.423 118.543 655.423 116.4C655.508 114.257 655.551 111.986 655.551 109.586C655.551 106.586 654.437 104.271 652.208 102.643C650.065 100.929 647.451 100.071 644.365 100.071C642.137 100.071 640.251 100.414 638.708 101.1C638.708 103.071 638.28 105.086 637.423 107.143C636.565 109.2 635.365 110.957 633.823 112.414C632.365 113.786 630.565 114.471 628.423 114.471C626.537 114.471 625.037 113.957 623.923 112.929C622.894 111.814 622.38 110.486 622.38 108.943C622.38 106.886 623.323 104.957 625.208 103.157C627.18 101.271 629.665 99.6857 632.665 98.4C635.665 97.0286 638.794 95.9572 642.051 95.1857C645.308 94.4143 648.223 94.0286 650.794 94.0286C653.965 94.0286 656.88 94.6286 659.537 95.8286C662.28 96.9429 664.465 98.6572 666.094 100.971C667.808 103.2 668.665 105.986 668.665 109.329C668.665 111.386 668.623 114.086 668.537 117.429C668.451 120.686 668.365 124.2 668.28 127.971C668.28 131.657 668.237 135.171 668.151 138.514C668.065 141.857 668.023 144.557 668.023 146.614C668.023 149.357 669.223 150.729 671.623 150.729C673.165 150.729 675.523 150.214 678.694 149.186C679.037 149.614 679.251 150.086 679.337 150.6C679.508 151.114 679.637 151.586 679.723 152.014C677.58 154.329 675.308 156 672.908 157.029C670.594 158.057 668.237 158.571 665.837 158.571ZM655.165 146.614L655.423 127.329C647.537 128.357 642.094 130.029 639.094 132.343C636.18 134.657 634.723 137.614 634.723 141.214C634.723 144.214 635.494 146.529 637.037 148.157C638.665 149.7 640.68 150.471 643.08 150.471C644.623 150.471 646.337 150.129 648.223 149.443C650.194 148.757 652.508 147.814 655.165 146.614Z" fill="currentColor"></path><rect x="715" y="65" width="195" height="105" rx="52.5" fill="currentColor" fill-opacity="0.05"></rect><path d="M767.529 142.875L754.049 107.938H762.552L769.309 127.582C769.705 128.812 770.078 130.032 770.43 131.24C770.781 132.449 771.078 133.559 771.32 134.569H771.616C771.858 133.559 772.144 132.449 772.473 131.24C772.825 130.032 773.198 128.812 773.594 127.582L780.186 107.938H788.689L775.472 142.875H767.529ZM810.856 143.633C806.901 143.633 803.528 142.71 800.737 140.865C797.969 138.997 795.871 136.305 794.442 132.79C793.014 129.252 792.3 124.989 792.3 120.001V118.255C792.3 113.245 793.014 108.982 794.442 105.467C795.871 101.929 797.969 99.2373 800.737 97.3916C803.528 95.5239 806.901 94.5901 810.856 94.5901C814.789 94.5901 818.129 95.5129 820.875 97.3586C823.644 99.2043 825.731 101.907 827.138 105.467C828.566 109.004 829.28 113.267 829.28 118.255V120.001C829.28 124.989 828.577 129.252 827.171 132.79C825.764 136.327 823.677 139.019 820.908 140.865C818.162 142.71 814.811 143.633 810.856 143.633ZM810.889 136.382C813.064 136.382 814.877 135.789 816.327 134.602C817.799 133.416 818.898 131.658 819.623 129.329C820.348 126.978 820.711 124.066 820.711 120.595V117.694C820.711 114.223 820.337 111.311 819.59 108.96C818.865 106.609 817.777 104.84 816.327 103.654C814.877 102.445 813.064 101.841 810.889 101.841C808.714 101.841 806.879 102.434 805.385 103.621C803.912 104.785 802.792 106.554 802.023 108.927C801.276 111.278 800.902 114.201 800.902 117.694V120.595C800.902 124.044 801.287 126.945 802.056 129.296C802.825 131.647 803.945 133.416 805.418 134.602C806.89 135.789 808.714 136.382 810.889 136.382ZM838.988 143.205C838 143.205 837.099 142.985 836.286 142.545C835.495 142.106 834.879 141.491 834.44 140.7C834.001 139.909 833.781 139.019 833.781 138.03C833.781 137.019 834.001 136.118 834.44 135.327C834.879 134.536 835.495 133.921 836.286 133.482C837.099 133.042 838 132.823 838.988 132.823C839.977 132.823 840.867 133.042 841.658 133.482C842.449 133.921 843.064 134.536 843.504 135.327C843.943 136.118 844.163 137.019 844.163 138.03C844.163 139.019 843.943 139.909 843.504 140.7C843.064 141.491 842.449 142.106 841.658 142.545C840.867 142.985 839.977 143.205 838.988 143.205ZM857.365 142.875V104.511L846.39 111.663V103.357L858.453 95.3481H865.802V142.875H857.365Z" fill="currentColor"></path></svg></a></div><div class="mx-auto flex w-full"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 border-input text-primary hover:border-primary/15 border hover:bg-overlay-hover py-2 max-w-full px-3 shadow-none sm:w-80 focus-visible:z-1 mx-auto h-full w-full rounded-full bg-surface-l1" type="button"><div class="flex items-center justify-between sm:w-full gap-4"><div class="flex items-center justify-start gap-2"><span class="inline-flex items-center justify-center p-0 m-0 w-4 h-4 text-muted" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-4 h-4" focusable="false" style="fill:currentColor"><path d="m18.031 16.617 4.283 4.282-1.415 1.415-4.282-4.283A8.96 8.96 0 0 1 11 20c-4.968 0-9-4.032-9-9s4.032-9 9-9 9 4.032 9 9a8.96 8.96 0 0 1-1.969 5.617m-2.006-.742A6.98 6.98 0 0 0 18 11c0-3.867-3.133-7-7-7s-7 3.133-7 7 3.133 7 7 7a6.98 6.98 0 0 0 4.875-1.975z"></path></svg></span><p class="text-sm text-muted hidden sm:block">Search</p></div><span class="hidden sm:block"><div class="bg-foreground/10 text-muted inline-flex items-center rounded-md px-1 py-0.5 text-center font-sans text-xs font-normal tracking-widest rtl:space-x-reverse"><span>âŒ˜</span><span class="text-xs">K</span></div></span></div></button></div><div class="flex items-center gap-2 justify-self-end"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover px-4 py-2 w-9 h-9 flex-shrink-0" type="button" id="radix-_R_7apfiumdb_" aria-haspopup="menu" aria-expanded="false" data-state="closed"><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 rotate-0 scale-100 transition-all dark:-rotate-90 dark:scale-0" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M12 18a6 6 0 1 1 0-12 6 6 0 0 1 0 12m0-2a4 4 0 1 0 0-8 4 4 0 0 0 0 8M11 1h2v3h-2zm0 19h2v3h-2zM3.515 4.929l1.414-1.414L7.05 5.636 5.636 7.05zM16.95 18.364l1.414-1.414 2.121 2.121-1.414 1.414zm2.121-14.85 1.414 1.415-2.121 2.121-1.414-1.414zM5.636 16.95l1.414 1.414-2.121 2.121-1.414-1.414zM23 11v2h-3v-2zM4 11v2H1v-2z"></path></svg></span><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 absolute rotate-90 scale-0 transition-all dark:rotate-0 dark:scale-100" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M10 7a7 7 0 0 0 12 4.9v.1c0 5.523-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2h.1A6.98 6.98 0 0 0 10 7m-6 5a8 8 0 0 0 15.062 3.762A9 9 0 0 1 8.238 4.938 8 8 0 0 0 4 12"></path></svg></span><span class="sr-only">Toggle theme</span></button></div></div><div class="flex h-full items-center md:hidden justify-between max-w-full py-6 px-4 w-full mx-auto pt-8"><div class="flex items-center"><div class="-ml-2"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover h-9 w-9" type="button" aria-label="Toggle table of contents"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-list h-6 w-6"><path d="M3 12h.01"></path><path d="M3 18h.01"></path><path d="M3 6h.01"></path><path d="M8 12h13"></path><path d="M8 18h13"></path><path d="M8 6h13"></path></svg></button></div><a class="cursor-pointer" href="/"><svg width="160" height="auto" viewBox="0 0 955 225" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M99.6937 159.214C90.008 159.214 81.5652 157.414 74.3652 153.814C67.1652 150.214 61.5509 144.986 57.5223 138.129C53.5794 131.271 51.608 123.043 51.608 113.443C51.608 103.843 53.5794 95.4857 57.5223 88.3714C61.5509 81.2572 67.1652 75.7286 74.3652 71.7857C81.6509 67.8429 90.1794 65.8714 99.9509 65.8714C103.208 65.8714 106.679 66.1286 110.365 66.6429C114.051 67.0714 117.222 67.6714 119.879 68.4429C121.508 68.8714 123.008 69.2572 124.379 69.6C125.751 69.9429 127.122 70.1143 128.494 70.1143C129.522 70.1143 130.551 69.9857 131.579 69.7286C131.751 73.5 131.922 77.4 132.094 81.4286C132.265 85.4572 132.522 89.6572 132.865 94.0286C131.065 94.2857 129.565 94.3714 128.365 94.2857C126.651 86.4 123.522 80.5714 118.979 76.8C114.437 72.9429 108.394 71.0143 100.851 71.0143C94.8509 71.0143 89.708 72.1286 85.4223 74.3572C81.2223 76.5 77.7937 79.4572 75.1366 83.2286C72.5652 87 70.6794 91.3714 69.4794 96.3429C68.2794 101.229 67.6794 106.457 67.6794 112.029C67.6794 120.171 68.9223 127.371 71.408 133.629C73.8937 139.886 77.6652 144.814 82.7223 148.414C87.8652 151.929 94.2937 153.686 102.008 153.686C104.408 153.686 107.065 153.471 109.979 153.043C112.894 152.529 115.679 151.757 118.337 150.729V134.529C118.337 131.871 118.208 129.814 117.951 128.357C117.779 126.814 117.222 125.7 116.279 125.014C115.422 124.329 114.008 123.857 112.037 123.6C110.151 123.257 107.537 122.957 104.194 122.7C103.937 121.329 103.937 119.957 104.194 118.586C105.994 118.586 108.179 118.629 110.751 118.714C113.322 118.714 115.894 118.757 118.465 118.843C121.122 118.843 123.308 118.843 125.022 118.843C127.679 118.843 130.722 118.8 134.151 118.714C137.665 118.629 140.665 118.586 143.151 118.586C143.322 119.871 143.322 121.2 143.151 122.571C139.637 123 137.108 123.429 135.565 123.857C134.022 124.286 133.079 125.143 132.737 126.429C132.394 127.714 132.222 129.9 132.222 132.986V137.1C132.222 141.129 132.308 144.514 132.479 147.257C132.737 150 132.951 151.971 133.122 153.171C121.208 157.2 110.065 159.214 99.6937 159.214ZM148.19 157.414C147.933 156.043 147.933 154.714 148.19 153.429C151.105 153.257 153.248 153 154.619 152.657C155.99 152.229 156.89 151.371 157.319 150.086C157.748 148.8 157.962 146.743 157.962 143.914V115.114C157.962 111.771 157.79 109.286 157.448 107.657C157.19 106.029 156.376 104.914 155.005 104.314C153.719 103.629 151.49 103.071 148.319 102.643C148.062 101.443 148.062 100.329 148.319 99.3C151.748 98.6143 155.09 97.8429 158.348 96.9857C161.605 96.0429 165.033 94.8429 168.633 93.3857L170.819 94.1572V105.471C176.819 97.8429 182.948 94.0286 189.205 94.0286C192.205 94.0286 194.433 94.8429 195.89 96.4714C197.348 98.0143 198.076 99.7714 198.076 101.743C198.076 104.057 197.305 105.857 195.762 107.143C194.219 108.343 192.462 108.943 190.49 108.943C188.862 108.943 187.233 108.514 185.605 107.657C184.062 106.8 182.905 105.471 182.133 103.671C179.219 103.671 176.605 104.829 174.29 107.143C172.062 109.371 170.948 111.986 170.948 114.986V142.629C170.948 145.971 171.119 148.371 171.462 149.829C171.89 151.286 172.919 152.229 174.548 152.657C176.262 153 179.005 153.257 182.776 153.429C182.948 154.629 182.948 155.957 182.776 157.414C179.862 157.414 176.862 157.371 173.776 157.286C170.69 157.2 167.519 157.157 164.262 157.157C161.09 157.157 158.262 157.2 155.776 157.286C153.376 157.371 150.848 157.414 148.19 157.414ZM229.285 158.829C223.028 158.829 217.542 157.5 212.828 154.843C208.199 152.1 204.599 148.371 202.028 143.657C199.457 138.857 198.171 133.371 198.171 127.2C198.171 120.514 199.499 114.686 202.157 109.714C204.899 104.743 208.714 100.886 213.599 98.1429C218.485 95.4 224.099 94.0286 230.442 94.0286C236.699 94.0286 242.142 95.4 246.771 98.1429C251.399 100.886 254.999 104.657 257.571 109.457C260.142 114.257 261.428 119.7 261.428 125.786C261.428 132.043 260.057 137.7 257.314 142.757C254.657 147.729 250.928 151.671 246.128 154.586C241.328 157.414 235.714 158.829 229.285 158.829ZM212.699 125.657C212.699 134.4 214.114 141.343 216.942 146.486C219.857 151.543 224.185 154.071 229.928 154.071C235.414 154.071 239.614 151.671 242.528 146.871C245.442 141.986 246.899 135.471 246.899 127.329C246.899 118.671 245.442 111.771 242.528 106.629C239.614 101.486 235.371 98.9143 229.799 98.9143C224.314 98.9143 220.071 101.271 217.071 105.986C214.157 110.7 212.699 117.257 212.699 125.657ZM267.394 157.414C267.308 157.071 267.265 156.729 267.265 156.386C267.265 156.043 267.265 155.7 267.265 155.357C267.265 155.014 267.265 154.714 267.265 154.457C267.265 154.114 267.308 153.771 267.394 153.429C270.308 153.257 272.451 153 273.822 152.657C275.194 152.229 276.094 151.371 276.522 150.086C276.951 148.8 277.165 146.743 277.165 143.914V79.5C277.165 76.8429 276.908 74.8714 276.394 73.5857C275.965 72.2143 274.979 71.2714 273.437 70.7572C271.979 70.1572 269.751 69.7286 266.751 69.4714C266.665 69.1286 266.622 68.8286 266.622 68.5714C266.622 68.3143 266.622 68.0572 266.622 67.8C266.622 67.4572 266.622 67.1572 266.622 66.9C266.622 66.6429 266.665 66.3429 266.751 66C270.179 65.5714 273.694 64.9286 277.294 64.0714C280.894 63.1286 284.579 61.8429 288.351 60.2143L290.537 60.9857C290.451 62.8714 290.365 65.0143 290.279 67.4143C290.279 69.8143 290.279 72.4286 290.279 75.2572V122.957C291.308 122.957 292.165 122.786 292.851 122.443C293.537 122.1 294.094 121.757 294.522 121.414C294.694 121.243 295.037 120.943 295.551 120.514C296.065 120 296.965 119.1 298.251 117.814C299.537 116.529 301.379 114.6 303.779 112.029C306.008 109.543 307.765 107.614 309.051 106.243C310.422 104.786 311.108 103.586 311.108 102.643C311.108 101.957 310.508 101.4 309.308 100.971C308.194 100.457 306.651 100.157 304.679 100.071C304.594 99.7286 304.551 99.3857 304.551 99.0429C304.551 98.7 304.551 98.3572 304.551 98.0143C304.551 97.6714 304.551 97.3286 304.551 96.9857C304.551 96.6429 304.594 96.3 304.679 95.9572C306.394 95.9572 308.537 96 311.108 96.0857C313.765 96.1714 316.122 96.2143 318.179 96.2143C319.208 96.2143 320.665 96.2143 322.551 96.2143C324.522 96.1286 326.494 96.0857 328.465 96.0857C330.437 96.0857 331.894 96.0857 332.837 96.0857C332.922 96.4286 332.965 96.7714 332.965 97.1143C333.051 97.4572 333.094 97.8 333.094 98.1429C333.094 98.4857 333.051 98.8286 332.965 99.1714C332.965 99.4286 332.922 99.7286 332.837 100.071C328.379 100.157 324.608 101.271 321.522 103.414C318.437 105.471 315.479 107.914 312.651 110.743L303.394 120L321.137 143.4C323.022 145.886 324.565 147.857 325.765 149.314C327.051 150.686 328.422 151.671 329.879 152.271C331.337 152.871 333.351 153.257 335.922 153.429C336.094 154.629 336.094 155.957 335.922 157.414C334.808 157.414 333.137 157.371 330.908 157.286C328.765 157.2 325.379 157.157 320.751 157.157C320.065 157.157 319.037 157.157 317.665 157.157C316.294 157.157 315.008 157.243 313.808 157.414C313.808 156.471 313.294 155.186 312.265 153.557C311.237 151.843 310.422 150.6 309.822 149.829C309.565 149.4 308.922 148.5 307.894 147.129C306.865 145.671 305.622 144 304.165 142.114C302.794 140.143 301.379 138.171 299.922 136.2C298.465 134.143 297.137 132.343 295.937 130.8C294.994 129.514 294.094 128.529 293.237 127.843C292.465 127.071 291.479 126.686 290.279 126.686V142.629C290.279 145.971 290.408 148.371 290.665 149.829C291.008 151.286 291.737 152.229 292.851 152.657C294.051 153 295.851 153.257 298.251 153.429C298.422 154.714 298.422 156.043 298.251 157.414C296.022 157.414 293.665 157.371 291.179 157.286C288.779 157.2 286.165 157.157 283.337 157.157C280.594 157.157 277.894 157.2 275.237 157.286C272.579 157.371 269.965 157.414 267.394 157.414ZM369.34 157.414C366.94 157.414 364.454 157.371 361.883 157.286C359.311 157.2 356.526 157.157 353.526 157.157C350.783 157.157 347.997 157.2 345.169 157.286C342.426 157.371 339.769 157.414 337.197 157.414C336.94 156.043 336.94 154.714 337.197 153.429C340.111 153.257 342.254 153 343.626 152.657C344.997 152.229 345.897 151.371 346.326 150.086C346.754 148.8 346.969 146.743 346.969 143.914V115.114C346.969 111.771 346.84 109.286 346.583 107.657C346.326 106.029 345.511 104.914 344.14 104.314C342.854 103.629 340.583 103.071 337.326 102.643C337.069 101.443 337.069 100.329 337.326 99.3C341.097 98.6143 344.697 97.7572 348.126 96.7286C351.554 95.7 354.854 94.5857 358.026 93.3857L360.211 94.1572C360.126 96.8143 360.04 99.3 359.954 101.614C359.954 103.929 359.954 106.114 359.954 108.171V142.629C359.954 145.971 360.126 148.371 360.469 149.829C360.897 151.286 361.754 152.229 363.04 152.657C364.411 153 366.511 153.257 369.34 153.429C369.597 154.714 369.597 156.043 369.34 157.414ZM343.626 71.5286C343.626 69.0429 344.483 66.9429 346.197 65.2286C347.997 63.5143 350.14 62.6572 352.626 62.6572C355.026 62.6572 357.083 63.5143 358.797 65.2286C360.597 66.9429 361.497 69 361.497 71.4C361.497 73.6286 360.64 75.6857 358.926 77.5715C357.211 79.3714 355.026 80.2714 352.369 80.2714C349.969 80.2714 347.911 79.4143 346.197 77.7C344.483 75.9857 343.626 73.9286 343.626 71.5286ZM372.678 188.914C372.592 187.543 372.592 186.214 372.678 184.929C375.678 184.757 377.864 184.457 379.235 184.029C380.607 183.6 381.464 182.743 381.807 181.457C382.235 180.257 382.45 178.286 382.45 175.543V115.114C382.45 111.771 382.278 109.286 381.935 107.657C381.678 106.029 380.864 104.914 379.492 104.314C378.207 103.629 375.978 103.071 372.807 102.643C372.635 101.443 372.635 100.329 372.807 99.3C376.321 98.6143 379.75 97.8 383.092 96.8572C386.435 95.9143 389.907 94.7572 393.507 93.3857L395.307 94.2857C395.221 96.4286 395.178 98.2714 395.178 99.8143C395.178 101.271 395.178 102.686 395.178 104.057C398.521 100.543 401.821 98.0143 405.078 96.4714C408.335 94.8429 411.807 94.0286 415.492 94.0286C420.892 94.0286 425.435 95.4429 429.121 98.2714C432.892 101.1 435.764 104.786 437.735 109.329C439.707 113.871 440.692 118.8 440.692 124.114C440.692 130.371 439.321 136.157 436.578 141.471C433.921 146.7 430.192 150.9 425.392 154.071C420.592 157.243 415.021 158.829 408.678 158.829C406.192 158.829 403.835 158.614 401.607 158.186C399.378 157.843 397.278 157.329 395.307 156.643V174C395.307 177.343 395.564 179.743 396.078 181.2C396.592 182.657 397.707 183.557 399.421 183.9C401.135 184.329 403.835 184.629 407.521 184.8C407.607 186.171 407.607 187.543 407.521 188.914C404.607 188.914 401.65 188.871 398.65 188.786C395.735 188.7 392.521 188.657 389.007 188.657C385.664 188.657 382.792 188.7 380.392 188.786C377.992 188.871 375.421 188.914 372.678 188.914ZM395.178 146.1C398.864 151.414 403.75 154.071 409.835 154.071C414.121 154.071 417.507 152.871 419.992 150.471C422.564 148.071 424.407 144.943 425.521 141.086C426.721 137.229 427.321 133.157 427.321 128.871C427.321 124.586 426.764 120.386 425.65 116.271C424.535 112.157 422.692 108.771 420.121 106.114C417.635 103.371 414.207 102 409.835 102C404.607 102 399.721 104.529 395.178 109.586V146.1ZM477.335 158.829C471.25 158.829 466.107 157.414 461.907 154.586C457.707 151.757 454.493 147.986 452.264 143.271C450.121 138.471 449.05 133.2 449.05 127.457C449.05 121.543 450.164 116.057 452.393 111C454.707 105.943 458.05 101.871 462.421 98.7857C466.793 95.6143 472.107 94.0286 478.364 94.0286C485.907 94.0286 491.778 96.3 495.978 100.843C500.264 105.3 502.407 111.086 502.407 118.2C502.407 119.057 502.364 119.829 502.278 120.514C502.278 121.114 502.235 121.629 502.15 122.057L461.65 121.671C461.65 122.014 461.65 122.314 461.65 122.571C461.65 130.971 463.578 137.571 467.435 142.371C471.293 147.171 476.693 149.571 483.635 149.571C489.464 149.571 495.207 147.686 500.864 143.914C501.721 144.943 502.364 145.929 502.793 146.871C495.507 154.843 487.021 158.829 477.335 158.829ZM462.035 116.914L488.65 116.4C488.735 116.229 488.778 116.014 488.778 115.757C488.778 115.414 488.778 115.2 488.778 115.114C488.778 110.486 487.75 106.629 485.693 103.543C483.721 100.457 480.764 98.9143 476.821 98.9143C473.135 98.9143 469.921 100.414 467.178 103.414C464.435 106.414 462.721 110.914 462.035 116.914ZM559.644 158.957L557.587 158.057L557.073 149.186C554.073 152.443 550.987 154.886 547.816 156.514C544.73 158.057 541.302 158.829 537.53 158.829C532.216 158.829 527.544 157.414 523.516 154.586C519.573 151.671 516.53 147.9 514.387 143.271C512.244 138.643 511.173 133.629 511.173 128.229C511.173 121.971 512.502 116.271 515.159 111.129C517.902 105.986 521.716 101.871 526.602 98.7857C531.573 95.6143 537.359 94.0286 543.959 94.0286C545.93 94.0286 547.987 94.2 550.13 94.5429C552.273 94.8 554.502 95.2714 556.816 95.9572V79.5C556.816 76.8429 556.559 74.8714 556.044 73.5857C555.53 72.2143 554.502 71.2714 552.959 70.7572C551.502 70.1572 549.273 69.7286 546.273 69.4714C546.016 68.3572 546.016 67.2 546.273 66C549.702 65.5714 553.216 64.9286 556.816 64.0714C560.416 63.1286 564.102 61.8429 567.873 60.2143L570.059 60.9857C569.973 62.8714 569.887 65.0143 569.802 67.4143C569.802 69.8143 569.802 72.4286 569.802 75.2572V139.029C569.802 142.286 569.93 144.729 570.187 146.357C570.445 147.986 571.216 149.143 572.502 149.829C573.787 150.429 575.973 150.986 579.059 151.5C579.316 152.614 579.316 153.771 579.059 154.971C575.63 155.486 572.287 156.043 569.03 156.643C565.773 157.243 562.644 158.014 559.644 158.957ZM556.944 106.886C553.259 101.829 548.416 99.3 542.416 99.3C536.502 99.3 532.044 101.486 529.044 105.857C526.044 110.143 524.544 116.1 524.544 123.729C524.544 128.186 525.144 132.471 526.344 136.586C527.544 140.7 529.516 144.086 532.259 146.743C535.002 149.4 538.644 150.729 543.187 150.729C548.93 150.729 553.516 148.243 556.944 143.271V106.886ZM615.699 157.414C613.299 157.414 610.813 157.371 608.242 157.286C605.67 157.2 602.885 157.157 599.885 157.157C597.142 157.157 594.356 157.2 591.527 157.286C588.785 157.371 586.127 157.414 583.556 157.414C583.299 156.043 583.299 154.714 583.556 153.429C586.47 153.257 588.613 153 589.985 152.657C591.356 152.229 592.256 151.371 592.685 150.086C593.113 148.8 593.327 146.743 593.327 143.914V115.114C593.327 111.771 593.199 109.286 592.942 107.657C592.685 106.029 591.87 104.914 590.499 104.314C589.213 103.629 586.942 103.071 583.685 102.643C583.427 101.443 583.427 100.329 583.685 99.3C587.456 98.6143 591.056 97.7572 594.485 96.7286C597.913 95.7 601.213 94.5857 604.385 93.3857L606.57 94.1572C606.485 96.8143 606.399 99.3 606.313 101.614C606.313 103.929 606.313 106.114 606.313 108.171V142.629C606.313 145.971 606.485 148.371 606.827 149.829C607.256 151.286 608.113 152.229 609.399 152.657C610.77 153 612.87 153.257 615.699 153.429C615.956 154.714 615.956 156.043 615.699 157.414ZM589.985 71.5286C589.985 69.0429 590.842 66.9429 592.556 65.2286C594.356 63.5143 596.499 62.6572 598.985 62.6572C601.385 62.6572 603.442 63.5143 605.156 65.2286C606.956 66.9429 607.856 69 607.856 71.4C607.856 73.6286 606.999 75.6857 605.285 77.5715C603.57 79.3714 601.385 80.2714 598.727 80.2714C596.327 80.2714 594.27 79.4143 592.556 77.7C590.842 75.9857 589.985 73.9286 589.985 71.5286ZM665.837 158.571C660.18 158.571 656.623 155.743 655.165 150.086C649.08 155.914 642.865 158.829 636.523 158.829C632.151 158.829 628.423 157.543 625.337 154.971C622.337 152.314 620.837 148.671 620.837 144.043C620.837 132.729 632.365 125.614 655.423 122.7C655.423 120.643 655.423 118.543 655.423 116.4C655.508 114.257 655.551 111.986 655.551 109.586C655.551 106.586 654.437 104.271 652.208 102.643C650.065 100.929 647.451 100.071 644.365 100.071C642.137 100.071 640.251 100.414 638.708 101.1C638.708 103.071 638.28 105.086 637.423 107.143C636.565 109.2 635.365 110.957 633.823 112.414C632.365 113.786 630.565 114.471 628.423 114.471C626.537 114.471 625.037 113.957 623.923 112.929C622.894 111.814 622.38 110.486 622.38 108.943C622.38 106.886 623.323 104.957 625.208 103.157C627.18 101.271 629.665 99.6857 632.665 98.4C635.665 97.0286 638.794 95.9572 642.051 95.1857C645.308 94.4143 648.223 94.0286 650.794 94.0286C653.965 94.0286 656.88 94.6286 659.537 95.8286C662.28 96.9429 664.465 98.6572 666.094 100.971C667.808 103.2 668.665 105.986 668.665 109.329C668.665 111.386 668.623 114.086 668.537 117.429C668.451 120.686 668.365 124.2 668.28 127.971C668.28 131.657 668.237 135.171 668.151 138.514C668.065 141.857 668.023 144.557 668.023 146.614C668.023 149.357 669.223 150.729 671.623 150.729C673.165 150.729 675.523 150.214 678.694 149.186C679.037 149.614 679.251 150.086 679.337 150.6C679.508 151.114 679.637 151.586 679.723 152.014C677.58 154.329 675.308 156 672.908 157.029C670.594 158.057 668.237 158.571 665.837 158.571ZM655.165 146.614L655.423 127.329C647.537 128.357 642.094 130.029 639.094 132.343C636.18 134.657 634.723 137.614 634.723 141.214C634.723 144.214 635.494 146.529 637.037 148.157C638.665 149.7 640.68 150.471 643.08 150.471C644.623 150.471 646.337 150.129 648.223 149.443C650.194 148.757 652.508 147.814 655.165 146.614Z" fill="currentColor"></path><rect x="715" y="65" width="195" height="105" rx="52.5" fill="currentColor" fill-opacity="0.05"></rect><path d="M767.529 142.875L754.049 107.938H762.552L769.309 127.582C769.705 128.812 770.078 130.032 770.43 131.24C770.781 132.449 771.078 133.559 771.32 134.569H771.616C771.858 133.559 772.144 132.449 772.473 131.24C772.825 130.032 773.198 128.812 773.594 127.582L780.186 107.938H788.689L775.472 142.875H767.529ZM810.856 143.633C806.901 143.633 803.528 142.71 800.737 140.865C797.969 138.997 795.871 136.305 794.442 132.79C793.014 129.252 792.3 124.989 792.3 120.001V118.255C792.3 113.245 793.014 108.982 794.442 105.467C795.871 101.929 797.969 99.2373 800.737 97.3916C803.528 95.5239 806.901 94.5901 810.856 94.5901C814.789 94.5901 818.129 95.5129 820.875 97.3586C823.644 99.2043 825.731 101.907 827.138 105.467C828.566 109.004 829.28 113.267 829.28 118.255V120.001C829.28 124.989 828.577 129.252 827.171 132.79C825.764 136.327 823.677 139.019 820.908 140.865C818.162 142.71 814.811 143.633 810.856 143.633ZM810.889 136.382C813.064 136.382 814.877 135.789 816.327 134.602C817.799 133.416 818.898 131.658 819.623 129.329C820.348 126.978 820.711 124.066 820.711 120.595V117.694C820.711 114.223 820.337 111.311 819.59 108.96C818.865 106.609 817.777 104.84 816.327 103.654C814.877 102.445 813.064 101.841 810.889 101.841C808.714 101.841 806.879 102.434 805.385 103.621C803.912 104.785 802.792 106.554 802.023 108.927C801.276 111.278 800.902 114.201 800.902 117.694V120.595C800.902 124.044 801.287 126.945 802.056 129.296C802.825 131.647 803.945 133.416 805.418 134.602C806.89 135.789 808.714 136.382 810.889 136.382ZM838.988 143.205C838 143.205 837.099 142.985 836.286 142.545C835.495 142.106 834.879 141.491 834.44 140.7C834.001 139.909 833.781 139.019 833.781 138.03C833.781 137.019 834.001 136.118 834.44 135.327C834.879 134.536 835.495 133.921 836.286 133.482C837.099 133.042 838 132.823 838.988 132.823C839.977 132.823 840.867 133.042 841.658 133.482C842.449 133.921 843.064 134.536 843.504 135.327C843.943 136.118 844.163 137.019 844.163 138.03C844.163 139.019 843.943 139.909 843.504 140.7C843.064 141.491 842.449 142.106 841.658 142.545C840.867 142.985 839.977 143.205 838.988 143.205ZM857.365 142.875V104.511L846.39 111.663V103.357L858.453 95.3481H865.802V142.875H857.365Z" fill="currentColor"></path></svg></a></div><div class="flex items-center gap-1"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover px-4 py-2 w-9 h-9 flex-shrink-0 [&amp;_svg]:!w-5" type="button" id="radix-_R_aipfiumdb_" aria-haspopup="menu" aria-expanded="false" data-state="closed"><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 rotate-0 scale-100 transition-all dark:-rotate-90 dark:scale-0" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M12 18a6 6 0 1 1 0-12 6 6 0 0 1 0 12m0-2a4 4 0 1 0 0-8 4 4 0 0 0 0 8M11 1h2v3h-2zm0 19h2v3h-2zM3.515 4.929l1.414-1.414L7.05 5.636 5.636 7.05zM16.95 18.364l1.414-1.414 2.121 2.121-1.414 1.414zm2.121-14.85 1.414 1.415-2.121 2.121-1.414-1.414zM5.636 16.95l1.414 1.414-2.121 2.121-1.414-1.414zM23 11v2h-3v-2zM4 11v2H1v-2z"></path></svg></span><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 absolute rotate-90 scale-0 transition-all dark:rotate-0 dark:scale-100" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M10 7a7 7 0 0 0 12 4.9v.1c0 5.523-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2h.1A6.98 6.98 0 0 0 10 7m-6 5a8 8 0 0 0 15.062 3.762A9 9 0 0 1 8.238 4.938 8 8 0 0 0 4 12"></path></svg></span><span class="sr-only">Toggle theme</span></button><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover h-9 w-9" type="button"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-search h-5 w-5"><circle cx="11" cy="11" r="8"></circle><path d="m21 21-4.3-4.3"></path></svg></button></div></div></header><div class="bg-surface-base fixed right-0 top-16 z-50 h-[calc(100vh-4rem)] w-full transform border-l transition-transform duration-300 ease-in-out sm:w-1/2 md:hidden translate-x-full"><div class="flex flex-col gap-4 p-4"><div class="flex flex-row gap-2"><button class="focus-visible:ring-ring inline-flex items-center gap-x-2 whitespace-nowrap text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 border-input text-primary hover:border-primary/15 border hover:bg-overlay-hover py-2 max-w-full shadow-none sm:w-80 h-10 w-full justify-start rounded-full bg-surface-l1 px-4" type="button"><div class="flex items-center justify-between sm:w-full gap-4"><div class="flex items-center justify-start gap-2"><span class="inline-flex items-center justify-center p-0 m-0 w-4 h-4 text-muted" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-4 h-4" focusable="false" style="fill:currentColor"><path d="m18.031 16.617 4.283 4.282-1.415 1.415-4.282-4.283A8.96 8.96 0 0 1 11 20c-4.968 0-9-4.032-9-9s4.032-9 9-9 9 4.032 9 9a8.96 8.96 0 0 1-1.969 5.617m-2.006-.742A6.98 6.98 0 0 0 18 11c0-3.867-3.133-7-7-7s-7 3.133-7 7 3.133 7 7 7a6.98 6.98 0 0 0 4.875-1.975z"></path></svg></span><p class="text-sm text-muted hidden sm:block">Search</p></div><span class="hidden sm:block"><div class="bg-foreground/10 text-muted inline-flex items-center rounded-md px-1 py-0.5 text-center font-sans text-xs font-normal tracking-widest rtl:space-x-reverse"><span>âŒ˜</span><span class="text-xs">K</span></div></span></div></button></div></div></div><div><div class="min-[1350px]:grid min-[1350px]:grid-cols-[1fr_3fr_1fr]"><nav class="bg-surface-base hidden h-[calc(100vh-4rem)] overflow-y-auto px-6 pb-32 min-[1350px]:sticky min-[1350px]:top-16 min-[1350px]:block scrollbar-none [-ms-overflow-style:none] [scrollbar-width:none] [&amp;::-webkit-scrollbar]:hidden [overscroll-behavior:contain] pt-8"><ul class="space-y-2 text-sm"><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#carbamazepine" class="transition-opacity hover:opacity-100 opacity-50">Carbamazepine</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#medical-uses" class="transition-opacity hover:opacity-100 opacity-50">Medical uses</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#adverse-effects" class="transition-opacity hover:opacity-100 opacity-50">Adverse effects</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#pharmacogenetics" class="transition-opacity hover:opacity-100 opacity-50">Pharmacogenetics</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#interactions" class="transition-opacity hover:opacity-100 opacity-50">Interactions</a></li><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#pharmacology" class="transition-opacity hover:opacity-100 opacity-50">Pharmacology</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#mechanism-of-action" class="transition-opacity hover:opacity-100 opacity-50">Mechanism of action</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#pharmacokinetics" class="transition-opacity hover:opacity-100 opacity-50">Pharmacokinetics</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#history" class="transition-opacity hover:opacity-100 opacity-50">History</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#society-and-culture" class="transition-opacity hover:opacity-100 opacity-50">Society and culture</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#environmental-impact" class="transition-opacity hover:opacity-100 opacity-50">Environmental impact</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#brand-names" class="transition-opacity hover:opacity-100 opacity-50">Brand names</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#references" class="transition-opacity hover:opacity-100 opacity-50">References</a></li></ul></nav><div class="relative top-16 pb-32 pt-8 px-4 md:px-8"><div class="mx-auto max-w-[850px]"><button data-state="closed" type="button" class="flex items-center"><div class="text-fg-tertiary mb-2 flex cursor-help items-center gap-2 text-sm"><span class="inline-flex items-center justify-center p-0 m-0" data-namespace="@xai/icons" data-slot="icon" style="height:16px;width:16px"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 33 33" aria-hidden="true" class="" focusable="false" style="fill:currentColor;height:16px;width:16px"><path fill="currentColor" d="m13.237 21.04 11.082-8.19c.543-.4 1.32-.244 1.578.38 1.363 3.288.754 7.241-1.957 9.955-2.71 2.714-6.482 3.31-9.93 1.954l-3.765 1.745c5.401 3.697 11.96 2.782 16.059-1.324 3.251-3.255 4.258-7.692 3.317-11.693l.008.009c-1.365-5.878.336-8.227 3.82-13.031q.123-.17.247-.345l-4.585 4.59v-.014L13.234 21.044M10.95 23.031c-3.877-3.707-3.208-9.446.1-12.755 2.446-2.449 6.454-3.448 9.952-1.979L24.76 6.56c-.677-.49-1.545-1.017-2.54-1.387A12.465 12.465 0 0 0 8.675 7.901c-3.519 3.523-4.625 8.94-2.725 13.561 1.42 3.454-.907 5.898-3.251 8.364-.83.874-1.664 1.749-2.335 2.674l10.583-9.466"></path></svg></span><span>Fact-checked by Grok<!-- --> <!-- -->4 days ago</span></div></button><article class="text-[16px]"><h1 id="carbamazepine" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Carbamazepine<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<span class="mb-4 block break-words text-[1em] leading-7"><strong>Carbamazepine</strong> , sold under the brand name <strong>Tegretol</strong> among others, is an <span class="inline text-[1em] leading-7">anticonvulsant medication</span> used in the treatment of <span class="inline text-[1em] leading-7">epilepsy</span> and <span class="inline text-[1em] leading-7">neuropathic pain</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_bqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> It is used as an adjunctive treatment in <span class="inline text-[1em] leading-7">schizophrenia</span> along with other medications and as a <span class="inline text-[1em] leading-7">second-line</span> agent in <span class="inline text-[1em] leading-7">bipolar disorder</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_kqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_lqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_mqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup> Carbamazepine appears to work as well as <span class="inline text-[1em] leading-7">phenytoin</span> and <span class="inline text-[1em] leading-7">valproate</span> for focal and generalized seizures.<a href="https://doi.org/10.1002/14651858.CD001388.pub3" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">6</a> It is not effective for <span class="inline text-[1em] leading-7">absence</span> or <span class="inline text-[1em] leading-7">myoclonic seizures</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_12qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Carbamazepine was discovered in 1953 by Swiss chemist Walter Schindler.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_21abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_31abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup> It was first marketed in 1962.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_51abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[7]</sup> It is available as a <span class="inline text-[1em] leading-7">generic medication</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_91abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[8]</sup> It is on the <span class="inline text-[1em] leading-7">World Health Organization&#x27;s List of Essential Medicines</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d1abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup> In 2023, it was the 185th most commonly prescribed medication in the United States, with more than 2 million prescriptions.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_f1abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[10]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_g1abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[11]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Photoswitchable analogues of carbamazepine have been developed to control its pharmacological activity locally and on demand using light (<span class="inline text-[1em] leading-7">photopharmacology</span>), with the purpose of reducing the adverse systemic effects of the drug.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_41qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[12]</sup> One of these light-regulated compounds (carbadiazocine, based on a bridged <span class="inline text-[1em] leading-7">azobenzene</span> or <span class="inline text-[1em] leading-7">diazocine</span>) has been shown to produce analgesia with noninvasive illumination <em>in vivo</em> in a rat model of <span class="inline text-[1em] leading-7">neuropathic pain</span>.</span>













































































































































<!-- -->
<h2 id="medical-uses" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Medical uses<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">Carbamazepine is typically used for the treatment of <span class="inline text-[1em] leading-7">seizure disorders</span> and <span class="inline text-[1em] leading-7">neuropathic pain</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_63abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> It is used <span class="inline text-[1em] leading-7">off-label</span> as a second-line treatment for bipolar disorder and in combination with an <span class="inline text-[1em] leading-7">antipsychotic</span> in some cases of <span class="inline text-[1em] leading-7">schizophrenia</span> when treatment with a conventional antipsychotic alone has failed.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_e3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_f3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup> However, evidence does not support its usage for schizophrenia.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_h3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup> It is not effective for <span class="inline text-[1em] leading-7">absence seizures</span> or <span class="inline text-[1em] leading-7">myoclonic seizures</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_n3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup> Although carbamazepine may have a similar effectiveness (as measured by people continuing to use a medication) and efficacy (as measured by the medicine reducing seizure recurrence and improving remission) when compared to <span class="inline text-[1em] leading-7">phenytoin</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_q3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[15]</sup> and <span class="inline text-[1em] leading-7">valproate</span> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_u3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[16]</sup>, choice of medication should be evaluated on an individual basis as further research is needed to determine which medication is most helpful for people with newly-onset seizures.</span>
<span class="mb-4 block break-words text-[1em] leading-7">In the United States, carbamazepine is <span class="inline text-[1em] leading-7">indicated</span> for the treatment of <span class="inline text-[1em] leading-7">epilepsy</span> (including complex partial seizures (psychomotor, temporal lobe), generalized <span class="inline text-[1em] leading-7">tonic-clonic seizures</span> and <span class="inline text-[1em] leading-7">mixed seizures</span>), <span class="inline text-[1em] leading-7">trigeminal neuralgia</span>, and glossopharyngeal neuralgia. <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c3qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d3qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_e3qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[18]</sup> Carbamazepine is the only medication that is approved by the <span class="inline text-[1em] leading-7">Food and Drug Administration</span> for the treatment of trigeminal neuralgia.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i3qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[18]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">A controlled-release formulation is available; a 2016 Cochrane review found tentative evidence of fewer side effects but no clear difference in efficacy.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_24abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[19]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">It has also been shown to improve symptoms of &quot;typewriter tinnitus&quot;, a type of tinnitus caused by the neurovascular compression of the cochleovestibular nerve. <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_24qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup></span>
<h2 id="adverse-effects" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Adverse effects<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">In the US, the label for carbamazepine contains boxed warnings and precautions concerning:<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_25qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup></span>
<ul class="marker:text-primary my-4 ml-6 list-disc space-y-2 text-[1em]">
<li class="text-[1em]">effects on the <span class="inline text-[1em] leading-7">body&#x27;s production of red blood cells, white blood cells, and platelets</span>: rarely, there are major effects of <span class="inline text-[1em] leading-7">aplastic anemia</span> and <span class="inline text-[1em] leading-7">agranulocytosis</span> reported and more commonly, there are minor changes such as decreased <span class="inline text-[1em] leading-7">white blood cell</span> or <span class="inline text-[1em] leading-7">platelet</span> counts, including bone marrow suppression, but these do not progress to more serious problems.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_626abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup></li>
<li class="text-[1em]">increased risks of suicide<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_146abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup></li>
<li class="text-[1em]">increased risks of <span class="inline text-[1em] leading-7">hyponatremia</span> and <span class="inline text-[1em] leading-7">SIADH</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2m6abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_366abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[21]</sup></li>
<li class="text-[1em]">risk of seizures, if the person stops taking the drug abruptly<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_186abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup></li>
<li class="text-[1em]">risks to the fetus in women who are pregnant, specifically congenital malformations like <span class="inline text-[1em] leading-7">spina bifida</span>, and developmental disorders.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2a6abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2q6abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[22]</sup></li>
<li class="text-[1em]"><span class="inline text-[1em] leading-7">Stevensâ€“Johnson syndrome</span> and toxic epidermal necrolysis<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1s6abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup></li>
</ul>
<span class="mb-4 block break-words text-[1em] leading-7">Common <span class="inline text-[1em] leading-7">adverse effects</span> may include drowsiness, dizziness, headaches and migraines, <span class="inline text-[1em] leading-7">ataxia</span>, nausea, vomiting, and/or constipation. <span class="inline text-[1em] leading-7">Alcohol</span> use while taking carbamazepine may lead to enhanced depression of the <span class="inline text-[1em] leading-7">central nervous system</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a6qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup> Less common side effects may include increased risk of seizures in people with <span class="inline text-[1em] leading-7">mixed seizure disorders</span>,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_e6qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[23]</sup> <span class="inline text-[1em] leading-7">abnormal heart rhythms</span>, blurry or <span class="inline text-[1em] leading-7">double vision</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_k6qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup> Rare postmarketing reports include <span class="inline text-[1em] leading-7">hepatitis</span>, <span class="inline text-[1em] leading-7">pancreatitis</span>, and an auditory side effect have been made, whereby patients perceive sounds about a <span class="inline text-[1em] leading-7">semitone</span> lower than previously; this unusual side effect is usually not noticed by most people, and disappears after the person stops taking carbamazepine.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_s6qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[24]</sup></span>
<h3 id="pharmacogenetics" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Pharmacogenetics<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Serious skin reactions such as <span class="inline text-[1em] leading-7">Stevensâ€“Johnson syndrome</span> (SJS) or <span class="inline text-[1em] leading-7">toxic epidermal necrolysis</span> (TEN) due to carbamazepine therapy are more common in people with a particular <span class="inline text-[1em] leading-7">human leukocyte antigen</span> gene-variant (<span class="inline text-[1em] leading-7">allele</span>), <span class="inline text-[1em] leading-7">HLA-B*1502</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c7qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup> <span class="inline text-[1em] leading-7">Odds ratios</span> for the development of SJS or TEN in people who carry the allele can be in the double, triple or even quadruple digits, depending on the population studied.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_g7qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[25]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_h7qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[26]</sup> <span class="inline text-[1em] leading-7">HLA-B*1502</span> occurs almost exclusively in people with ancestry across broad areas of Asia, but has a very low or absent frequency in European, Japanese, Korean and African populations.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_l7qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_m7qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[27]</sup> However, the HLA-A<em>31:01 allele has been shown to be a strong predictor of both mild and severe adverse reactions, such as the <span class="inline text-[1em] leading-7">DRESS</span> form of severe cutaneous reactions, to carbamazepine among Japanese, Chinese, Korean, and Europeans.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4o7qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[26]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5o7qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[28]</sup> It is suggested that carbamazepine acts as a potent antigen that binds to the antigen-presenting area of HLA-B</em>1502 alike, triggering an everlasting activation signal on immature CD8-T cells, thus resulting in widespread cytotoxic reactions like SJS/TEN.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_q7qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[29]</sup></span>
<h2 id="interactions" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Interactions<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">Carbamazepine has a potential for drug interactions.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_28qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[30]</sup> Drugs that decrease breaking down of carbamazepine or otherwise increase its levels include erythromycin,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_48qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[31]</sup> cimetidine, and certain calcium channel blockers (e.g., verapamil and diltiazem).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_68qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[30]</sup> Grapefruit juice raises the bioavailability of carbamazepine by inhibiting the enzyme CYP3A4 in the gut wall and in the liver.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_88qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup> Lower levels of carbamazepine are seen when administered with phenobarbital, phenytoin, or primidone, which can result in breakthrough seizure activity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a8qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[32]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Valproic acid and valnoctamide both inhibit microsomal epoxide hydrolase (mEH), the enzyme responsible for the breakdown of the active metabolite carbamazepine-10,11-epoxide into inactive metabolites.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_29abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[33]</sup> By inhibiting mEH, valproic acid and valnoctamide cause a build-up of the active metabolite, prolonging the effects of carbamazepine and delaying its excretion.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Carbamazepine, as an inducer of cytochrome P450 enzymes, may increase clearance of many drugs, decreasing their concentration in the blood to subtherapeutic levels and reducing their desired effects.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_29qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[32]</sup> Drugs that are more rapidly metabolized with carbamazepine include warfarin, lamotrigine, phenytoin, theophylline, valproic acid,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_49qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[30]</sup> many benzodiazepines,<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_69qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[34]</sup> and methadone.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_89qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[35]</sup> Carbamazepine also increases the metabolism of the hormones in birth control pills and can reduce their effectiveness, potentially leading to unexpected pregnancies.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a9qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[30]</sup></span>
<h1 id="pharmacology" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Pharmacology<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<h2 id="mechanism-of-action" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Mechanism of action<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">Carbamazepine is a <span class="inline text-[1em] leading-7">sodium channel blocker</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4babav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[36]</sup> It binds preferentially to <span class="inline text-[1em] leading-7">voltage-gated sodium channels</span> in their inactive conformation, which prevents repetitive and sustained firing of an <span class="inline text-[1em] leading-7">action potential</span>. Carbamazepine has effects on serotonin systems but the relevance to its antiseizure effects is uncertain. There is evidence that it is a <span class="inline text-[1em] leading-7">serotonin releasing agent</span> and possibly even a <span class="inline text-[1em] leading-7">serotonin reuptake inhibitor</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ebabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[37]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_fbabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[38]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gbabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[39]</sup> It has been suggested that carbamazepine can also block <span class="inline text-[1em] leading-7">voltage-gated calcium channels</span>, which will reduce neurotransmitter release.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_kbabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[40]</sup></span>
<h2 id="pharmacokinetics" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Pharmacokinetics<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">Carbamazepine is relatively slowly but practically completely absorbed after administration by mouth. Highest concentrations in the <span class="inline text-[1em] leading-7">blood plasma</span> are reached after 4 to 24 hours depending on the dosage form. <span class="inline text-[1em] leading-7">Slow release</span> tablets result in about 15% lower absorption and 25% lower peak plasma concentrations than ordinary tablets, as well as in less fluctuation of the concentration, but not in significantly lower <span class="inline text-[1em] leading-7">minimum concentrations</span>.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8cabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[41]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In plasma, carbamazepine constitutes the majority (about 80-85%) of circulating active forms, with the epoxide metabolite comprising 15-20%. The remainder consists of other metabolites; 70 to 80% of residues is bound to <span class="inline text-[1em] leading-7">plasma proteins</span>. Concentrations in breast milk are 25 to 60% of those in the blood plasma.</span>
<span class="mb-4 block break-words text-[1em] leading-7">Carbamazepine is pharmacologically active and is mainly metabolized by CYP3A4 to the active metabolite carbamazepine-10,11-<span class="inline text-[1em] leading-7">epoxide</span>, which has comparable anticonvulsant activity. The epoxide is then inactivated by microsomal epoxide hydrolase (mEH) to carbamazepine-<em>trans</em>-10,11-<span class="inline text-[1em] leading-7">diol</span> and further to its <span class="inline text-[1em] leading-7">glucuronides</span>. Other metabolites include various <span class="inline text-[1em] leading-7">hydroxyl</span> derivatives and carbamazepine-<span class="inline text-[1em] leading-7"><em>N</em></span>-glucuronide.</span>
<span class="mb-4 block break-words text-[1em] leading-7">The <span class="inline text-[1em] leading-7">plasma half-life</span> is about 35 to 40 hours when carbamazepine is given as single dose, but it is a strong <span class="inline text-[1em] leading-7">inducer</span> of liver enzymes, and the plasma half-life shortens to about 12 to 17 hours when it is given repeatedly. The half-life can be further shortened to 9â€“10 hours by other enzyme inducers such as <span class="inline text-[1em] leading-7">phenytoin</span> or <span class="inline text-[1em] leading-7">phenobarbital</span>. About 70% are excreted via the urine, almost exclusively in form of its metabolites, and 30% via the faeces.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_adqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[41]</sup></span>
<h2 id="history" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">History<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<span class="mb-4 block break-words text-[1em] leading-7">Carbamazepine was discovered by chemist Walter Schindler at J.R. Geigy AG (now part of <span class="inline text-[1em] leading-7">Novartis</span>) in <span class="inline text-[1em] leading-7">Basel</span>, <span class="inline text-[1em] leading-7">Switzerland</span>, in 1953.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8eqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[43]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9eqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[44]</sup> It was first marketed under the brand name Tegretol in Switzerland in 1962 for <span class="inline text-[1em] leading-7">trigeminal neuralgia</span> (formerly known as tic douloureux), and for epilepsy in 1963.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_deqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[43]</sup> It has been used as an anticonvulsant and antiepileptic in the United Kingdom since 1965, and has been approved in the United States since 1968.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_feqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Carbamazepine was studied for bipolar disorder throughout the 1970s.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2fabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[45]</sup></span>
<h2 id="society-and-culture" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Society and culture<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="environmental-impact" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Environmental impact<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Carbamazepine and its bio-transformation products have been detected in wastewater treatment plant effluent.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2gqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[46]</sup>: 224 Field and laboratory studies have been conducted to understand the accumulation of carbamazepine in food plants grown in soil treated with <span class="inline text-[1em] leading-7">sludge</span>, which vary with respect to the concentrations of carbamazepine present in sludge and in the concentrations of sludge in the soil. Taking into account only studies that used concentrations commonly found in the environment, a 2015 review of pre-2015 literature concluded that &quot;the accumulation of carbamazepine into plants grown in soil amended with biosolids poses a <em><span class="inline text-[1em] leading-7">de minimis</span></em> risk to human health according to the approach.&quot;<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8gqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[46]</sup>: 227 Recent studies as of 2025 confirm the persistence of carbamazepine in surface waters, with concentrations up to 0.1 Î¼g/L reported.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_agqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[47]</sup></span>
<h3 id="brand-names" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Brand names<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Carbamazepine is available worldwide under many brand names including Tegretol.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2hqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[48]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Photoswitchable analogues of carbamazepine have been developed to control its pharmacological activity locally and on demand using light (photopharmacology), with the purpose of reducing adverse systemic effects. One of these light-regulated compounds (carbadiazocine, based on a bridged azobenzene or diazocine) has been shown to produce analgesia with noninvasive illumination <em>in vivo</em> in a rat model of neuropathic pain.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4iabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[49]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Recent studies as of 2025 have also investigated maternal exposure to environmentally relevant concentrations of carbamazepine, highlighting potential risks to fetal growth during pregnancy.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2iqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[50]</sup> Additionally, research on drug interactions demonstrated that carbamazepine, as a strong CYP3A inducer, reduces exposure to zongertinib by 63.5% when coadministered.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4iqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[51]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">A 2024 proposal to add carbamazepine to the WHO Model List of Essential Medicines for trigeminal neuralgia was not recommended for inclusion in the 2025 update.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_2jabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[52]</sup></span></article><div id="references" class="min-w-0 scroll-mt-8 overflow-hidden"><div class="text-[16px]"><h2 id="references" node="[object Object]" class="mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden">References</h2></div><ol class="columns-1 gap-x-12 [counter-reset:item] md:columns-2"><li id="3" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8d409411-aa9f-4f3a-a52c-fbcb0c3ec053" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Tegretol- carbamazepine suspension Tegretol- carbamazepine tablet Tegretol XR- carbamazepine tablet, extended release&quot;</a>. <em>DailyMed</em>. 16 May 2022. Retrieved 3 January 2023.</span></div></li><li id="1" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.drugs.com/monograph/carbamazepine.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Carbamazepine&quot;</a>. <em>The American Society of Health-System Pharmacists</em>. <a href="https://web.archive.org/web/20150227213125/http://www.drugs.com/monograph/carbamazepine.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 27 February 2015. Retrieved 28 March 2015.</span></div></li><li id="15" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Ceron-Litvoc D, Soares BG, Geddes J, Litvoc J, de Lima MS (January 2009). &quot;Comparison of carbamazepine and lithium in treatment of bipolar disorder: a systematic review of randomized controlled trials&quot;. <em>Human Psychopharmacology</em>. <strong>24</strong> (1): 19â€“28. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2Fhup.990" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/hup.990</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/19053079" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">19053079</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:5684931" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">5684931</a>.</span></div></li><li id="16" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Leucht S, Helfer B, Dold M, Kissling W, McGrath J, et al. (Cochrane Schizophrenia Group) (May 2014). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032545" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Carbamazepine for schizophrenia&quot;</a>. <em>The Cochrane Database of Systematic Reviews</em>. <strong>2014</strong> (5): CD001258. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2F14651858.CD001258.pub3" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/14651858.CD001258.pub3</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032545" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">7032545</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/24789267" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">24789267</a>.</span></div></li><li id="7" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Smith HS (2009). <a href="https://books.google.com/books?id=iTgy62MWnK4C&amp;pg=PA460" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300"><em>Current therapy in pain</em></a>. Philadelphia: Saunders/Elsevier. p. 460. <span class="inline text-[1em] leading-7">ISBN</span> 978-1-4160-4836-7. <a href="https://web.archive.org/web/20160305032812/https://books.google.ca/books?id=iTgy62MWnK4C&amp;pg=PA460" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 5 March 2016.</span></div></li><li id="8" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://worldwide.espacenet.com/patent/search/family/003449474/publication/US2948718A?q=US2948718A" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">US patent 2948718</a>, Walter Schindler, &quot;New n-heterocyclic compounds&quot;, published 9 August 1960, issued 9 August 1960, assigned to Geigy Chemical Corporation</span></div></li><li id="9" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">MoshÃ© S (2009). <a href="https://books.google.com/books?id=rFFzFzZJtasC&amp;pg=PR29" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300"><em>The treatment of epilepsy</em></a> (3 ed.). Chichester, UK: Wiley-Blackwell. p. xxix. <span class="inline text-[1em] leading-7">ISBN</span> 978-1-4443-1667-4. <a href="https://web.archive.org/web/20160305024852/https://books.google.ca/books?id=rFFzFzZJtasC&amp;pg=PR29" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 5 March 2016.</span></div></li><li id="10" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Porter NC (2008). <a href="https://books.google.com/books?id=uEghr21XY6wC&amp;pg=PA536" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Trigeminal Neuralgia: Surgical Perspective&quot;</a>. In Chin LS, Regine WF (eds.). <em>Principles and practice of stereotactic radiosurgery</em>. New York: Springer. p. 536. <span class="inline text-[1em] leading-7">ISBN</span> 978-0-387-71070-9. <a href="https://web.archive.org/web/20160305021147/https://books.google.ca/books?id=uEghr21XY6wC&amp;pg=PA536" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 5 March 2016.</span></div></li><li id="11" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Organization WH (2019). <em>World Health Organization model list of essential medicines: 21st list 2019</em>. Geneva: <span class="inline text-[1em] leading-7">World Health Organization</span>. <span class="inline text-[1em] leading-7">hdl</span>:<a href="https://hdl.handle.net/10665%2F325771" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10665/325771</a>. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.</span></div></li><li id="12" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://clincalc.com/DrugStats/Top300Drugs.aspx" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Top 300 of 2023&quot;</a>. <em>ClinCalc</em>. <a href="https://web.archive.org/web/20250812130026/https://clincalc.com/DrugStats/Top300Drugs.aspx" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 12 August 2025. Retrieved 12 August 2025.</span></div></li><li id="13" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://clincalc.com/DrugStats/Drugs/Carbamazepine" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Carbamazepine - Drug Usage Statistics&quot;</a>. <em>ClinCalc</em>. Retrieved 19 August 2025.</span></div></li><li id="14" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Camerin L, Maleeva G, Gomila-Juaneda A, SuÃ¡rez-Pereira I, Matera C, Prischich D, et al. (June 2024). <a href="https://doi.org/10.1002%2Fanie.202403636" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Photoswitchable carbamazepine analogs for non-invasive neuroinhibition in vivo&quot;</a>. <em>Angewandte Chemie</em>. <strong>63</strong> (38) e202403636. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/2024ACIE...63E3636C" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2024ACIE...63E3636C</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2Fanie.202403636" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/anie.202403636</a>. <span class="inline text-[1em] leading-7">hdl</span>:<a href="https://hdl.handle.net/2445%2F215169" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2445/215169</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/38887153" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">38887153</a>.</span></div></li><li id="2" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><span class="inline text-[1em] leading-7">Anvisa</span> (31 March 2023). <a href="https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;RDC NÂº 784 - Listas de SubstÃ¢ncias Entorpecentes, PsicotrÃ³picas, Precursoras e Outras sob Controle Especial&quot;</a> [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). <span class="inline text-[1em] leading-7">DiÃ¡rio Oficial da UniÃ£o</span> (published 4 April 2023). <a href="https://web.archive.org/web/20230803143925/https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 3 August 2023. Retrieved 16 August 2023.</span></div></li><li id="4" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7a1e523a-b377-43dc-b231-7591c4c888ea" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Carbamazepine Drug Label&quot;</a>. <a href="https://web.archive.org/web/20141208063739/http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7a1e523a-b377-43dc-b231-7591c4c888ea" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 8 December 2014.</span></div></li><li id="6" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Nevitt SJ, Marson AG, Tudur Smith C (July 2019). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637502" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review&quot;</a>. <em>The Cochrane Database of Systematic Reviews</em>. <strong>2019</strong> (7): CD001911. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2F14651858.CD001911.pub4" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/14651858.CD001911.pub4</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637502" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">6637502</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/31318037" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">31318037</a>.</span></div></li><li id="https://doi.org/10.1002/14651858.CD001030.pub2" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://doi.org/10.1002/14651858.CD001030.pub2" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://doi.org/10.1002/14651858.CD001030.pub2</a></span></div></li><li id="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8d409411-aa9f-4f3a-a52c-fbcb0c3ec053" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8d409411-aa9f-4f3a-a52c-fbcb0c3ec053" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8d409411-aa9f-4f3a-a52c-fbcb0c3ec053</a></span></div></li><li id="18" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Pino MA (19 January 2017). <a href="https://www.uspharmacist.com/article/trigeminal-neuralgia-a-lightning-bolt-of-pain" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Trigeminal Neuralgia: A &quot;Lightning Bolt&quot; of Pain&quot;</a>. <em>US Pharmacist</em>. <strong>42</strong> : 41â€“44.</span></div></li><li id="19" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Powell G, Saunders M, Rigby A, Marson AG (December 2016). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463840" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy&quot;</a>. <em>The Cochrane Database of Systematic Reviews</em>. <strong>12</strong> (4): CD007124. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2F14651858.CD007124.pub5" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/14651858.CD007124.pub5</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463840" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">6463840</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/27933615" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">27933615</a>.</span></div></li><li id="20" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Sunwoo, W., Jeon, Y., Bae, Y. et al. Typewriter tinnitus revisited: The typical symptoms and the initial response to carbamazepine are the most reliable diagnostic clues. Sci Rep 7, 10615 (2017). <a href="https://doi.org/10.1038/s41598-017-10798-w" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://doi.org/10.1038/s41598-017-10798-w</a></span></div></li><li id="22" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Gandelman MS (March 1994). &quot;Review of carbamazepine-induced hyponatremia&quot;. <em>Progress in Neuro-Psychopharmacology &amp; Biological Psychiatry</em>. <strong>18</strong> (2): 211â€“33. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2F0278-5846%2894%2990055-8" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/0278-5846(94)90055-8</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/8208974" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">8208974</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:36758508" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">36758508</a>.</span></div></li><li id="23" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Jentink J, Dolk H, Loane MA, Morris JK, Wellesley D, Garne E, et al. (December 2010). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996546" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study&quot;</a>. <em>BMJ</em>. <strong>341</strong> : c6581. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1136%2Fbmj.c6581" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1136/bmj.c6581</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996546" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2996546</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/21127116" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">21127116</a>.</span></div></li><li id="24" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Liu L, Zheng T, Morris MJ, Wallengren C, Clarke AL, Reid CA, et al. (November 2006). &quot;The mechanism of carbamazepine aggravation of absence seizures&quot;. <em>The Journal of Pharmacology and Experimental Therapeutics</em>. <strong>319</strong> (2): 790â€“8. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1124%2Fjpet.106.104968" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1124/jpet.106.104968</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/16895979" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16895979</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:7693614" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">7693614</a>.</span></div></li><li id="25" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Tateno A, Sawada K, Takahashi I, Hujiwara Y (August 2006). &quot;Carbamazepine-induced transient auditory pitch-perception deficit&quot;. <em>Pediatric Neurology</em>. <strong>35</strong> (2): 131â€“4. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.pediatrneurol.2006.01.011" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.pediatrneurol.2006.01.011</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/16876011" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">16876011</a>.</span></div></li><li id="26" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Kaniwa N, Saito Y (June 2013). <a href="https://doi.org/10.1038%2Fjhg.2013.37" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury&quot;</a>. <em>Journal of Human Genetics</em>. <strong>58</strong> (6): 317â€“26. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1038%2Fjhg.2013.37" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1038/jhg.2013.37</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/23635947" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">23635947</a>.</span></div></li><li id="27" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Amstutz U, Shear NH, Rieder MJ, Hwang S, Fung V, Nakamura H, et al. (April 2014). &quot;Recommendations for HLA-B<em>15:02 and HLA-A</em>31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions&quot;. <em>Epilepsia</em>. <strong>55</strong> (4): 496â€“506. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1111%2Fepi.12564" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1111/epi.12564</a>. <span class="inline text-[1em] leading-7">hdl</span>:<a href="https://hdl.handle.net/2429%2F63109" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2429/63109</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/24597466" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">24597466</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:41565230" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">41565230</a>.</span></div></li><li id="28" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Leckband SG, Kelsoe JR, Dunnenberger HM, George AL, Tran E, Berger R, et al. (September 2013). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3748365" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Clinical Pharmacogenetics Implementation Consortium guidelines for HLA-B genotype and carbamazepine dosing&quot;</a>. <em>Clinical Pharmacology and Therapeutics</em>. <strong>94</strong> (3): 324â€“8. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1038%2Fclpt.2013.103" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1038/clpt.2013.103</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3748365" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3748365</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/23695185" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">23695185</a>.</span></div></li><li id="29" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Garon SL, Pavlos RK, White KD, Brown NJ, Stone CA, Phillips EJ (September 2017). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555876" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Pharmacogenomics of off-target adverse drug reactions&quot;</a>. <em>British Journal of Clinical Pharmacology</em>. <strong>83</strong> (9): 1896â€“1911. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1111%2Fbcp.13294" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1111/bcp.13294</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555876" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">5555876</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/28345177" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">28345177</a>.</span></div></li><li id="30" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Jaruthamsophon K, Tipmanee V, Sangiemchoey A, Sukasem C, Limprasert P (March 2017). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372085" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;HLA-B*15:21 and carbamazepine-induced Stevens-Johnson syndrome: pooled-data and in silico analysis&quot;</a>. <em>Scientific Reports</em>. <strong>7</strong> (1) 45553. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/2017NatSR...745553J" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2017NatSR...745553J</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1038%2Fsrep45553" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1038/srep45553</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372085" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">5372085</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/28358139" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">28358139</a>.</span></div></li><li id="17" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Lexi-Comp (February 2009). <a href="http://www.merck.com/mmpe/lexicomp/carbamazepine.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Carbamazepine&quot;</a>. <em><span class="inline text-[1em] leading-7">The Merck Manual Professional</span></em>. <a href="https://web.archive.org/web/20101103035532/http://www.merck.com/mmpe/lexicomp/carbamazepine.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 3 November 2010. Retrieved on 3 May 2009.</span></div></li><li id="31" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Stafstrom CE, Nohria V, Loganbill H, Nahouraii R, Boustany RM, DeLong GR (January 1995). <a href="http://archpedi.ama-assn.org/cgi/pmidlookup?view=long&amp;pmid=7827672" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Erythromycin-induced carbamazepine toxicity: a continuing problem&quot;</a>. <em>Archives of Pediatrics &amp; Adolescent Medicine</em>. <strong>149</strong> (1): 99â€“101. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1001%2Farchpedi.1995.02170130101025" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1001/archpedi.1995.02170130101025</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/7827672" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">7827672</a>. <a href="https://archive.today/20240525023120/https://www.webcitation.org/5uKvQB98w?url=http://archpedi.ama-assn.org/cgi/pmidlookup%3Fview=long&amp;pmid=7827672" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 25 May 2024.</span></div></li><li id="32" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="http://www.emedicine.com/emerg/topic77.htm" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Carbamazepine Toxicity&quot;</a>. <em>eMedicine</em>. 2 February 2019. <a href="https://web.archive.org/web/20080704144842/http://emedicine.com/emerg/topic77.htm" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Archived</a> from the original on 4 July 2008.</span></div></li><li id="33" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Gonzalez FJ, Tukey RH (2006). &quot;Drug Metabolism&quot;. In Brunton L, Lazo J, Parker K (eds.). <span class="inline text-[1em] leading-7"><em>Goodman &amp; Gilman&#x27;s The Pharmacological Basis of Therapeutics</em></span> (11th ed.). New York: <span class="inline text-[1em] leading-7">McGraw-Hill</span>. p. <a href="https://archive.org/details/goodmangilmansph00brun_116/page/n104" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">79</a>. <span class="inline text-[1em] leading-7">ISBN</span> 978-0-07-142280-2.</span></div></li><li id="34" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Moody D (2004). <a href="https://archive.org/details/handbookofdrugin0000unse/page/3" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Drug interactions with benzodiazepines&quot;</a>. In Raymon LP, Mozayani A (eds.). <em>Handbook of Drug Interactions: a Clinical and Forensic Guide</em>. Humana. pp. <a href="https://archive.org/details/handbookofdrugin0000unse/page/3" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">3â€“88</a>. <span class="inline text-[1em] leading-7">ISBN</span> 978-1-58829-211-7.</span></div></li><li id="35" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Schlatter J, Madras JL, Saulnier JL, Poujade F (September 1999). &quot;[Drug interactions with methadone]&quot; [Drug interactions with methadone]. <em>Presse MÃ©dicale</em> (in French). <strong>28</strong> (25): 1381â€“4. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/10506872" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10506872</a>.</span></div></li><li id="36" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Rogawski MA, LÃ¶scher W, Rho JM (May 2016). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852797" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Mechanisms of Action of Antiseizure Drugs and the Ketogenic Diet&quot;</a>. <em>Cold Spring Harbor Perspectives in Medicine</em>. <strong>6</strong> (5): a022780. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1101%2Fcshperspect.a022780" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1101/cshperspect.a022780</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852797" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">4852797</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/26801895" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">26801895</a>.</span></div></li><li id="37" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Dailey JW, Reith ME, Steidley KR, Milbrandt JC, Jobe PC (October 1998). <a href="https://doi.org/10.1111%2Fj.1528-1157.1998.tb01290.x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Carbamazepine-induced release of serotonin from rat hippocampus in vitro&quot;</a>. <em>Epilepsia</em>. <strong>39</strong> (10): 1054â€“63. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1111%2Fj.1528-1157.1998.tb01290.x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1111/j.1528-1157.1998.tb01290.x</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/9776325" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">9776325</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:20382623" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">20382623</a>.</span></div></li><li id="38" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Dailey JW, Reith ME, Yan QS, Li MY, Jobe PC (June 1997). &quot;Carbamazepine increases extracellular serotonin concentration: lack of antagonism by tetrodotoxin or zero Ca2+&quot;. <em>European Journal of Pharmacology</em>. <strong>328</strong> (2â€“3): 153â€“62. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fs0014-2999%2897%2983041-5" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/s0014-2999(97)83041-5</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/9218697" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">9218697</a>.</span></div></li><li id="39" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Kawata Y, Okada M, Murakami T, Kamata A, Zhu G, Kaneko S (June 2001). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572811" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Pharmacological discrimination between effects of carbamazepine on hippocampal basal, Ca(2+)- and K(+)-evoked serotonin release&quot;</a>. <em>British Journal of Pharmacology</em>. <strong>133</strong> (4): 557â€“67. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1038%2Fsj.bjp.0704104" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1038/sj.bjp.0704104</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572811" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1572811</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/11399673" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">11399673</a>.</span></div></li><li id="40" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Gambeta E, Chichorro JG, Zamponi GW (January 2020). <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985973" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Trigeminal Neuralgia: an overview from pathophysiology to pharmacological treatments&quot;</a>. <em>Molecular Pain</em>. <strong>16</strong> 1744806920901890. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1177%2F1744806920901890" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1177/1744806920901890</a>. <span class="inline text-[1em] leading-7">PMC</span> <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985973" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">6985973</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/31908187" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">31908187</a>.</span></div></li><li id="41" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubchem.ncbi.nlm.nih.gov/compound/2554" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Carbamazepine&quot;</a>. <em>PubChem</em>. National Library of Medicine, National Institutes of Health, U.S. Department of Health and Human Services. Retrieved 6 May 2021.</span></div></li><li id="42" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Haberfeld H, ed. (2021). <em>Austria-Codex</em> (in German). Vienna: Ã–sterreichischer Apothekerverlag. Tegretol retard 400 mg-Filmtabletten.</span></div></li><li id="43" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Scott DF (1993). &quot;Chapter 8: Carbamazepine&quot;. <em>The History of Epileptic Therapy: An Account of How Medication was Developed</em>. History of Medicine Series. CRC Press. <span class="inline text-[1em] leading-7">ISBN</span> 978-1-85070-391-4.</span></div></li><li id="44" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Schindler W, HÃ¤fliger F (1954). &quot;Ãœber Derivate des Iminodibenzyls&quot;. <em><span class="inline text-[1em] leading-7">Helvetica Chimica Acta</span></em>. <strong>37</strong> (2): 472â€“83. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/1954HChAc..37..472S" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">1954HChAc..37..472S</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1002%2Fhlca.19540370211" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1002/hlca.19540370211</a>.</span></div></li><li id="45" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Okuma T, Kishimoto A (February 1998). &quot;A history of investigation on the mood stabilizing effect of carbamazepine in Japan&quot;. <em>Psychiatry and Clinical Neurosciences</em>. <strong>52</strong> (1): 3â€“12. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1111%2Fj.1440-1819.1998.tb00966.x" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1111/j.1440-1819.1998.tb00966.x</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/9682927" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">9682927</a>. <span class="inline text-[1em] leading-7">S2CID</span> <a href="https://api.semanticscholar.org/CorpusID:8480811" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">8480811</a>.</span></div></li><li id="46" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7">Prosser RS, Sibley PK (February 2015). &quot;Human health risk assessment of pharmaceuticals and personal care products in plant tissue due to biosolids and manure amendments, and wastewater irrigation&quot;. <em>Environment International</em>. <strong>75</strong> : 223â€“33. <span class="inline text-[1em] leading-7">Bibcode</span>:<a href="https://ui.adsabs.harvard.edu/abs/2015EnInt..75..223P" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">2015EnInt..75..223P</a>. <span class="inline text-[1em] leading-7">doi</span>:<a href="https://doi.org/10.1016%2Fj.envint.2014.11.020" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">10.1016/j.envint.2014.11.020</a>. <span class="inline text-[1em] leading-7">PMID</span> <a href="https://pubmed.ncbi.nlm.nih.gov/25486094" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">25486094</a>.</span></div></li><li id="https://doi.org/10.1016/j.chemosphere.2025.141234" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://doi.org/10.1016/j.chemosphere.2025.141234" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://doi.org/10.1016/j.chemosphere.2025.141234</a></span></div></li><li id="48" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.drugs.com/international/carbamazepine.html" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">&quot;Carbamazepine&quot;</a>. <em>Drugs.com</em>. Retrieved 27 October 2019.</span></div></li><li id="https://doi.org/10.1002/anie.202403636" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://doi.org/10.1002/anie.202403636" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://doi.org/10.1002/anie.202403636</a></span></div></li><li id="https://pubs.acs.org/doi/10.1021/acsomega.5c04235" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubs.acs.org/doi/10.1021/acsomega.5c04235" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubs.acs.org/doi/10.1021/acsomega.5c04235</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC11823298/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11823298/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC11823298/</a></span></div></li><li id="https://www.thelancet.com/pdfs/journals/laneur/PIIS1474-4422(25)00358-8.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.thelancet.com/pdfs/journals/laneur/PIIS1474-4422(25)00358-8.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.thelancet.com/pdfs/journals/laneur/PIIS1474-4422(25)00358-8.pdf</a></span></div></li></ol></div><div class="text-fg-secondary text-xs [&amp;_*]:mb-2"><hr class="border-border-l1 my-8 rounded-sm border-t"/>
<span class="mb-4 block break-words text-[1em] leading-7">The content is adapted from <a href="https://en.wikipedia.org/wiki/Carbamazepine" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">Wikipedia</a>, licensed under Creative Commons Attribution-ShareAlike 4.0 License.</span></div></div></div><div class="hidden min-[1400px]:block"></div></div></div><!--$--><!--/$--><div role="region" aria-label="Notifications (F8)" tabindex="-1" style="pointer-events:none"><ol tabindex="-1" class="pointer-events-none fixed top-0 z-[100] flex max-h-screen w-full flex-col-reverse p-4 max-sm:left-0 sm:bottom-0 sm:right-0 sm:top-auto sm:max-w-[420px] sm:flex-col pl-16 pr-2 pt-16 sm:px-4"></ol></div><script type="application/json" id="server-client-data-experimentation">{"status":"uninitialized"}</script><script src="/_next/static/chunks/webpack-e121ed42680f327e.js" nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4" id="_R_" async=""></script><script nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4">(self.__next_f=self.__next_f||[]).push([0])</script><script nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4">self.__next_f.push([1,"1:\"$Sreact.fragment\"\n3:I[91363,[],\"\"]\n4:I[23775,[],\"\"]\n5:I[57654,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"3699\",\"static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js\"],\"PageHeaderProvider\"]\n6:I[17618,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"3699\",\"static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js\"],\"HeaderContent\"]\n7:I[25529,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"6751\",\"static/chunks/app/page/%5Bslug%5D/not-found-69a3edc7db5749d6.js\"],\"default\"]\n9:I[6666,[],\"OutletBoundary\"]\nb:I[80415,[],\"AsyncMetadataOutlet\"]\nd:I[6666,[],\"ViewportBoundary\"]\nf:I[6666,[],\"MetadataBoundary\"]\n10:\"$Sreact.suspense\"\n12:I[95909,[\"4219\",\"static/chunks/app/global-error-4d07d20223cd4b4c.js\"],\"default\"]\n"])</script><script nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4">self.__next_f.push([1,"13:I[51498,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"ConstantsProvider\"]\n"])</script><script nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4">self.__next_f.push([1,"14:I[91073,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4">self.__next_f.push([1,"15:I[38642,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4">self.__next_f.push([1,"16:I[99648,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"default\"]\n"])</script><script nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4">self.__next_f.push([1,"17:I[78825,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4">self.__next_f.push([1,"18:I[8550,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"MixpanelProvider\"]\n"])</script><script nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4">self.__next_f.push([1,"19:I[12290,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"MobileTocProvider\"]\n"])</script><script nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4">self.__next_f.push([1,"1a:I[53947,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"NuqsAdapter\"]\n"])</script><script nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4">self.__next_f.push([1,"1b:I[91873,[\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8039\",\"static/chunks/app/error-4a29e9399afba038.js\"],\"default\"]\n1c:I[5091,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"4345\",\"static/chunks/app/not-found-dd95690acf732f18.js\"],\"default\"]\n"])</script><script nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4">self.__next_f.push([1,"1d:I[16091,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4">self.__next_f.push([1,":HL[\"/_next/static/media/1f2316909698f815.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/3d4419af2cf8609b.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/4dec29efcaeb336c.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/74452ea3ef0f9101.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/904ef0a86fe32a00.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/d886a03bcda7ad8f.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/e1447589d6f59c4b.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/f5a90156f8995c8c.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/css/62c4caba71dfda84.css\",\"style\",{\"nonce\":\"YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4\"}]\n:HL[\"/_next/static/css/eb3d87f98fe1565f.css\",\"style\",{\"nonce\":\"YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4\"}]\n:HL[\"/_next/static/css/1b5e561215938d4d.css\",\"style\",{\"nonce\":\"YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4\"}]\n:HL[\"/_next/static/css/0227d069a630d414.css\",\"style\",{\"nonce\":\"YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4\"}]\n:HL[\"/_next/static/css/f87fff2ab93d05a7.css\",\"style\",{\"nonce\":\"YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4\"}]\n"])</script><script nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4">self.__next_f.push([1,"0:{\"P\":null,\"b\":\"BpM29AX4fmgcUxZ_6t0le\",\"p\":\"\",\"c\":[\"\",\"page\",\"Carbamazepine\"],\"i\":false,\"f\":[[[\"\",{\"children\":[\"page\",{\"children\":[[\"slug\",\"Carbamazepine\",\"d\"],{\"children\":[\"__PAGE__\",{}]}]}]},\"$undefined\",\"$undefined\",true],[\"\",[\"$\",\"$1\",\"c\",{\"children\":[[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/62c4caba71dfda84.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4\"}],[\"$\",\"link\",\"1\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/eb3d87f98fe1565f.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4\"}],[\"$\",\"link\",\"2\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/1b5e561215938d4d.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4\"}],[\"$\",\"link\",\"3\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/0227d069a630d414.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4\"}]],\"$L2\"]}],{\"children\":[\"page\",[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":\"$undefined\",\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}],{\"children\":[[\"slug\",\"Carbamazepine\",\"d\"],[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L5\",null,{\"children\":[[\"$\",\"$L6\",null,{\"maxWidth\":\"full\",\"mobileOptions\":{\"right\":{\"showFixedIssues\":true,\"showThemeSwitcher\":true,\"showSearch\":true,\"showTableOfContents\":true}}}],[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"$L7\",null,{}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}]]}],{\"children\":[\"__PAGE__\",[\"$\",\"$1\",\"c\",{\"children\":[\"$L8\",[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/f87fff2ab93d05a7.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4\"}]],[\"$\",\"$L9\",null,{\"children\":[\"$La\",[\"$\",\"$Lb\",null,{\"promise\":\"$@c\"}]]}]]}],{},null,false]},null,false]},null,false]},null,false],[\"$\",\"$1\",\"h\",{\"children\":[null,[[\"$\",\"$Ld\",null,{\"children\":\"$Le\"}],[\"$\",\"meta\",null,{\"name\":\"next-size-adjust\",\"content\":\"\"}]],[\"$\",\"$Lf\",null,{\"children\":[\"$\",\"div\",null,{\"hidden\":true,\"children\":[\"$\",\"$10\",null,{\"fallback\":null,\"children\":\"$L11\"}]}]}]]}],false]],\"m\":\"$undefined\",\"G\":[\"$12\",[]],\"s\":false,\"S\":false}\n"])</script><script nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4">self.__next_f.push([1,"2:[\"$\",\"html\",null,{\"lang\":\"en\",\"className\":\"bg-surface-base antialiased\",\"suppressHydrationWarning\":true,\"children\":[[\"$\",\"head\",null,{\"children\":[[\"$\",\"title\",null,{\"children\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"type\":\"image/x-icon\",\"href\":\"/favicon.ico\",\"sizes\":\"48x48\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"href\":\"/images/icon-dark.png\",\"media\":\"(prefers-color-scheme: light)\",\"type\":\"image/png\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"href\":\"/images/icon-light.png\",\"media\":\"(prefers-color-scheme: dark)\",\"type\":\"image/png\"}],[\"$\",\"link\",null,{\"rel\":\"apple-touch-icon\",\"href\":\"/icon-192x192.png\"}],[\"$\",\"link\",null,{\"rel\":\"manifest\",\"href\":\"/manifest.webmanifest\"}],[\"$\",\"meta\",null,{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",null,{\"name\":\"googlebot\",\"content\":\"index, follow, max-snippet:-1\"}],[\"$\",\"meta\",null,{\"property\":\"og:title\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"property\":\"og:description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"meta\",null,{\"property\":\"og:url\",\"content\":\"https://grokipedia.com\"}],[\"$\",\"meta\",null,{\"property\":\"og:site_name\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"property\":\"og:locale\",\"content\":\"en_US\"}],[\"$\",\"meta\",null,{\"property\":\"og:type\",\"content\":\"website\"}],[\"$\",\"meta\",null,{\"property\":\"og:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:width\",\"content\":\"512\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:height\",\"content\":\"512\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:alt\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:creator\",\"content\":\"@Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:title\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}]]}],[\"$\",\"body\",null,{\"className\":\"flex h-[100svh] w-full flex-col __variable_13c637 __variable_8a0ba0 __variable_779740 __variable_2484fd __variable_525cc3 __variable_13486b\",\"children\":[[\"$\",\"$L13\",null,{\"children\":[\"$\",\"$L14\",null,{\"children\":[\"$\",\"$L15\",null,{\"defaultTheme\":\"dark\",\"nonce\":\"YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4\",\"children\":[\"$\",\"$L16\",null,{\"children\":[\"$\",\"$L17\",null,{\"children\":[\"$\",\"$L18\",null,{\"children\":[\"$\",\"$L19\",null,{\"children\":[\"$\",\"$L1a\",null,{\"children\":[[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$1b\",\"errorStyles\":[],\"errorScripts\":[],\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"$L1c\",null,{}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}],[\"$\",\"$L1d\",null,{}]]}]}]}]}]}]}]}]}],[\"$\",\"script\",null,{\"type\":\"application/json\",\"id\":\"server-client-data-experimentation\",\"children\":\"{\\\"status\\\":\\\"uninitialized\\\"}\"}]]}]]}]\n"])</script><script nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4">self.__next_f.push([1,"e:[[\"$\",\"meta\",\"0\",{\"charSet\":\"utf-8\"}],[\"$\",\"meta\",\"1\",{\"name\":\"viewport\",\"content\":\"width=device-width, initial-scale=1, interactive-widget=resizes-content\"}]]\na:null\n"])</script><script nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4">self.__next_f.push([1,"1e:I[42712,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"HydrationBoundary\"]\n"])</script><script nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4">self.__next_f.push([1,"21:I[6367,[],\"IconMark\"]\n1f:T47f3,"])</script><script nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4">self.__next_f.push([1,"# Carbamazepine\n\n**Carbamazepine** , sold under the brand name **Tegretol** among others, is an [anticonvulsant medication](Anticonvulsant_medication \"Anticonvulsant medication\") used in the treatment of [epilepsy](Epilepsy \"Epilepsy\") and [neuropathic pain](Neuropathic_pain \"Neuropathic pain\").[3][1] It is used as an adjunctive treatment in [schizophrenia](Schizophrenia \"Schizophrenia\") along with other medications and as a [second-line](Therapy#Lines_of_therapy \"Therapy\") agent in [bipolar disorder](Bipolar_disorder \"Bipolar disorder\").[1][15][16] Carbamazepine appears to work as well as [phenytoin](Phenytoin \"Phenytoin\") and [valproate](Valproate \"Valproate\") for focal and generalized seizures.[6](https://doi.org/10.1002/14651858.CD001388.pub3) It is not effective for [absence](Absence_seizure \"Absence seizure\") or [myoclonic seizures](Myoclonic_seizure \"Myoclonic seizure\").[1]\n\nCarbamazepine was discovered in 1953 by Swiss chemist Walter Schindler.[7][8] It was first marketed in 1962.[9] It is available as a [generic medication](Generic_medication \"Generic medication\").[10] It is on the [World Health Organization's List of Essential Medicines](WHO_Model_List_of_Essential_Medicines \"WHO Model List of Essential Medicines\").[11] In 2023, it was the 185th most commonly prescribed medication in the United States, with more than 2 million prescriptions.[12][13]\n\nPhotoswitchable analogues of carbamazepine have been developed to control its pharmacological activity locally and on demand using light ([photopharmacology](Photopharmacology \"Photopharmacology\")), with the purpose of reducing the adverse systemic effects of the drug.[14] One of these light-regulated compounds (carbadiazocine, based on a bridged [azobenzene](Azobenzene \"Azobenzene\") or [diazocine](https://en.wiktionary.org/wiki/diazocine \"wiktionary:diazocine\")) has been shown to produce analgesia with noninvasive illumination _in vivo_ in a rat model of [neuropathic pain](Neuropathic_pain \"Neuropathic pain\").\n\n| **Attribute** | **Details** |\n|---------------|-------------|\n| Trade names | Tegretol, others |\n| Other names | CBZ |\n| AHFS/Drugs.com | [Monograph](https://www.drugs.com/monograph/carbamazepine.html) |\n| MedlinePlus | [a682237](https://medlineplus.gov/druginfo/meds/a682237.html) |\n| License data | US [DailyMed](DailyMed \"DailyMed\"): [Carbamazepine](https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all\u0026query=Carbamazepine) |\n| Pregnancy category | AU: D |\n| Routes of administration | [By mouth](By_mouth \"By mouth\") |\n| Drug class | [Anticonvulsant](Anticonvulsant \"Anticonvulsant\")[1] |\n| ATC code | [N03AF01](ATC_code_N03 \"ATC code N03\") ([WHO](https://www.whocc.no/atc_ddd_index/?code=N03AF01)) |\n| Legal status | AU: [S4](Standard_for_the_Uniform_Scheduling_of_Medicines_and_Poisons#Schedule_4 \"Standard for the Uniform Scheduling of Medicines and Poisons\") (Prescription only)\u003cbr\u003eBR: [Class C1](Brazilian_Controlled_Drugs_and_Substances_Act#Class_C1 \"Brazilian Controlled Drugs and Substances Act\") (Other controlled substances)[2]\u003cbr\u003eCA: [â„ž-only](Prescription_drug \"Prescription drug\")\u003cbr\u003eUK: [POM](Prescription_drug \"Prescription drug\") (Prescription only)\u003cbr\u003eUS: [â„ž-only](Prescription_drug \"Prescription drug\")[3] |\n| Bioavailability | ~100%[4] |\n| Protein binding | 70â€“80%[4] |\n| Metabolism | [Liver](Liver \"Liver\") ([CYP3A4](CYP3A4 \"CYP3A4\"))[4] |\n| Metabolites | Active [epoxide](Epoxide \"Epoxide\") form (carbamazepine-10,11 epoxide)[4] |\n| Elimination half-life | 36 hours (single dose), 16â€“24 hours (repeated dosing)[4] |\n| Excretion | Urine (72%), feces (28%)[4] |\n| IUPAC name | 5 _H_ -dibenzo[_b_, _f_]azepine-5-carboxamide |\n| CAS Number | [298-46-4](https://commonchemistry.cas.org/detail?cas_rn=298-46-4)\u003cbr\u003e[85756-57-6](https://commonchemistry.cas.org/detail?cas_rn=85756-57-6\u0026title=) |\n| PubChem CID | [2554](https://pubchem.ncbi.nlm.nih.gov/compound/2554) |\n| IUPHAR/BPS | [5339](https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5339) |\n| DrugBank | [DB00564](https://www.drugbank.ca/drugs/DB00564) |\n| ChemSpider | [2457](https://www.chemspider.com/Chemical-Structure.2457.html) |\n| UNII | [33CM23913M](https://precision.fda.gov/uniisearch/srs/unii/33CM23913M) |\n| KEGG | [D00252](https://www.kegg.jp/entry/D00252) |\n| ChEBI | [CHEBI:3387](https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:3387) |\n| ChEMBL | [ChEMBL108](https://www.ebi.ac.uk/chembl/explore/compound/ChEMBL108) |\n| CompTox Dashboard (EPA) | [DTXSID4022731](https://comptox.epa.gov/dashboard/chemical/details/DTXSID4022731) |\n| ECHA InfoCard | [100.005.512](https://echa.europa.eu/substance-information/-/substanceinfo/100.005.512) |\n| Formula | C15H12N2O |\n| Molar mass | 236.274 gÂ·molâˆ’1 |\n| 3D model (JSmol) | [Interactive image](https://chemapps.stolaf.edu/jmol/jmol.php?model=c1ccc2c%28c1%29C%3DCc3ccccc3N2C%28%3DO%29N) |\n| SMILES | c1ccc2c(c1)C=Cc3ccccc3N2C(=O)N |\n| InChI | InChI=1S/C15H12N2O/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-10H,(H2,16,18)\u003cbr\u003eKey:FFGPTBGBLSHEPO-UHFFFAOYSA-N |\n## Medical uses\n\nCarbamazepine is typically used for the treatment of [seizure disorders](Seizure_disorders \"Seizure disorders\") and [neuropathic pain](Neuropathic_pain \"Neuropathic pain\").[1] It is used [off-label](Off-label_use \"Off-label use\") as a second-line treatment for bipolar disorder and in combination with an [antipsychotic](Antipsychotic \"Antipsychotic\") in some cases of [schizophrenia](Schizophrenia \"Schizophrenia\") when treatment with a conventional antipsychotic alone has failed.[1][15] However, evidence does not support its usage for schizophrenia.[16] It is not effective for [absence seizures](Absence_seizure \"Absence seizure\") or [myoclonic seizures](Myoclonic_seizure \"Myoclonic seizure\").[1] Although carbamazepine may have a similar effectiveness (as measured by people continuing to use a medication) and efficacy (as measured by the medicine reducing seizure recurrence and improving remission) when compared to [phenytoin](Phenytoin \"Phenytoin\")[6] and [valproate](Valproate \"Valproate\") [](https://doi.org/10.1002/14651858.CD001030.pub2), choice of medication should be evaluated on an individual basis as further research is needed to determine which medication is most helpful for people with newly-onset seizures.\n\nIn the United States, carbamazepine is [indicated](Indicated \"Indicated\") for the treatment of [epilepsy](Epilepsy \"Epilepsy\") (including complex partial seizures (psychomotor, temporal lobe), generalized [tonic-clonic seizures](Tonic-clonic_seizure \"Tonic-clonic seizure\") and [mixed seizures](Mixed_seizure \"Mixed seizure\")), [trigeminal neuralgia](Trigeminal_neuralgia \"Trigeminal neuralgia\"), and glossopharyngeal neuralgia. [](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8d409411-aa9f-4f3a-a52c-fbcb0c3ec053)[3][18] Carbamazepine is the only medication that is approved by the [Food and Drug Administration](Food_and_Drug_Administration \"Food and Drug Administration\") for the treatment of trigeminal neuralgia.[18]\n\nA controlled-release formulation is available; a 2016 Cochrane review found tentative evidence of fewer side effects but no clear difference in efficacy.[19]\n\nIt has also been shown to improve symptoms of \"typewriter tinnitus\", a type of tinnitus caused by the neurovascular compression of the cochleovestibular nerve. [20]\n## Adverse effects\n\nIn the US, the label for carbamazepine contains boxed warnings and precautions concerning:[3]\n\n* effects on the [body's production of red blood cells, white blood cells, and platelets](Hematology \"Hematology\"): rarely, there are major effects of [aplastic anemia](Aplastic_anemia \"Aplastic anemia\") and [agranulocytosis](Agranulocytosis \"Agranulocytosis\") reported and more commonly, there are minor changes such as decreased [white blood cell](Leukocyte \"Leukocyte\") or [platelet](Platelet \"Platelet\") counts, including bone marrow suppression, but these do not progress to more serious problems.[4]\n* increased risks of suicide[3]\n* increased risks of [hyponatremia](Hyponatremia \"Hyponatremia\") and [SIADH](SIADH \"SIADH\")[4][22]\n* risk of seizures, if the person stops taking the drug abruptly[4]\n* risks to the fetus in women who are pregnant, specifically congenital malformations like [spina bifida](Spina_bifida \"Spina bifida\"), and developmental disorders.[4][23]\n* [Stevensâ€“Johnson syndrome](Stevens%E2%80%93Johnson_syndrome \"Stevensâ€“Johnson syndrome\") and toxic epidermal necrolysis[3]\n\nCommon [adverse effects](Adverse_drug_reaction \"Adverse drug reaction\") may include drowsiness, dizziness, headaches and migraines, [ataxia](Ataxia \"Ataxia\"), nausea, vomiting, and/or constipation. [Alcohol](Alcohol_\\(drug\\) \"Alcohol \\(drug\\)\") use while taking carbamazepine may lead to enhanced depression of the [central nervous system](Central_nervous_system \"Central nervous system\").[4] Less common side effects may include increased risk of seizures in people with [mixed seizure disorders](Causes_of_seizures#Diseases \"Causes of seizures\"),[24] [abnormal heart rhythms](Heart_arrhythmia \"Heart arrhythmia\"), blurry or [double vision](Diplopia \"Diplopia \").[4] Rare postmarketing reports include [hepatitis](Hepatitis \"Hepatitis\"), [pancreatitis](Pancreatitis \"Pancreatitis\"), and an auditory side effect have been made, whereby patients perceive sounds about a [semitone](Semitone \"Semitone\") lower than previously; this unusual side effect is usually not noticed by most people, and disappears after the person stops taking carbamazepine.[25]\n\n### Pharmacogenetics\n\nSerious skin reactions such as [Stevensâ€“Johnson syndrome](Stevens%E2%80%93Johnson_syndrome \"Stevensâ€“Johnson syndrome\") (SJS) or [toxic epidermal necrolysis](Toxic_epidermal_necrolysis \"Toxic epidermal necrolysis\") (TEN) due to carbamazepine therapy are more common in people with a particular [human leukocyte antigen](Human_leukocyte_antigen \"Human leukocyte antigen\") gene-variant ([allele](Allele \"Allele\")), [HLA-B*1502](HLA-B75 \"HLA-B75\").[4] [Odds ratios](Odds_ratio \"Odds ratio\") for the development of SJS or TEN in people who carry the allele can be in the double, triple or even quadruple digits, depending on the population studied.[26][27] [HLA-B*1502](HLA-B75 \"HLA-B75\") occurs almost exclusively in people with ancestry across broad areas of Asia, but has a very low or absent frequency in European, Japanese, Korean and African populations.[4][28] However, the HLA-A*31:01 allele has been shown to be a strong predictor of both mild and severe adverse reactions, such as the [DRESS](Drug_reaction_with_eosinophilia_and_systemic_symptoms \"Drug reaction with eosinophilia and systemic symptoms\") form of severe cutaneous reactions, to carbamazepine among Japanese, Chinese, Korean, and Europeans.[27][29] It is suggested that carbamazepine acts as a potent antigen that binds to the antigen-presenting area of HLA-B*1502 alike, triggering an everlasting activation signal on immature CD8-T cells, thus resulting in widespread cytotoxic reactions like SJS/TEN.[30]\n## Interactions\n\nCarbamazepine has a potential for drug interactions.[17] Drugs that decrease breaking down of carbamazepine or otherwise increase its levels include erythromycin,[31] cimetidine, and certain calcium channel blockers (e.g., verapamil and diltiazem).[17] Grapefruit juice raises the bioavailability of carbamazepine by inhibiting the enzyme CYP3A4 in the gut wall and in the liver.[4] Lower levels of carbamazepine are seen when administered with phenobarbital, phenytoin, or primidone, which can result in breakthrough seizure activity.[32]\n\nValproic acid and valnoctamide both inhibit microsomal epoxide hydrolase (mEH), the enzyme responsible for the breakdown of the active metabolite carbamazepine-10,11-epoxide into inactive metabolites.[33] By inhibiting mEH, valproic acid and valnoctamide cause a build-up of the active metabolite, prolonging the effects of carbamazepine and delaying its excretion. \n\nCarbamazepine, as an inducer of cytochrome P450 enzymes, may increase clearance of many drugs, decreasing their concentration in the blood to subtherapeutic levels and reducing their desired effects.[32] Drugs that are more rapidly metabolized with carbamazepine include warfarin, lamotrigine, phenytoin, theophylline, valproic acid,[17] many benzodiazepines,[34] and methadone.[35] Carbamazepine also increases the metabolism of the hormones in birth control pills and can reduce their effectiveness, potentially leading to unexpected pregnancies.[17]\n# Pharmacology\n\n## Mechanism of action\n\nCarbamazepine is a [sodium channel blocker](Sodium_channel_blocker \"Sodium channel blocker\").[36] It binds preferentially to [voltage-gated sodium channels](Voltage_gated_sodium_channels \"Voltage gated sodium channels\") in their inactive conformation, which prevents repetitive and sustained firing of an [action potential](Action_potential \"Action potential\"). Carbamazepine has effects on serotonin systems but the relevance to its antiseizure effects is uncertain. There is evidence that it is a [serotonin releasing agent](Serotonin_releasing_agent \"Serotonin releasing agent\") and possibly even a [serotonin reuptake inhibitor](Serotonin_reuptake_inhibitor \"Serotonin reuptake inhibitor\").[37][38][39] It has been suggested that carbamazepine can also block [voltage-gated calcium channels](Voltage-gated_calcium_channel \"Voltage-gated calcium channel\"), which will reduce neurotransmitter release.[40]\n\n## Pharmacokinetics\n\nCarbamazepine is relatively slowly but practically completely absorbed after administration by mouth. Highest concentrations in the [blood plasma](Blood_plasma \"Blood plasma\") are reached after 4 to 24 hours depending on the dosage form. [Slow release](Slow_release \"Slow release\") tablets result in about 15% lower absorption and 25% lower peak plasma concentrations than ordinary tablets, as well as in less fluctuation of the concentration, but not in significantly lower [minimum concentrations](Cmin \"Cmin\").[41][42]\n\nIn plasma, carbamazepine constitutes the majority (about 80-85%) of circulating active forms, with the epoxide metabolite comprising 15-20%. The remainder consists of other metabolites; 70 to 80% of residues is bound to [plasma proteins](Plasma_protein \"Plasma protein\"). Concentrations in breast milk are 25 to 60% of those in the blood plasma.[42]\n\nCarbamazepine is pharmacologically active and is mainly metabolized by CYP3A4 to the active metabolite carbamazepine-10,11-[epoxide](Epoxide \"Epoxide\"), which has comparable anticonvulsant activity. The epoxide is then inactivated by microsomal epoxide hydrolase (mEH) to carbamazepine-*trans*-10,11-[diol](Diol \"Diol\") and further to its [glucuronides](Glucuronide \"Glucuronide\"). Other metabolites include various [hydroxyl](Hydroxyl \"Hydroxyl\") derivatives and carbamazepine-[*N*](Nitrogen \"Nitrogen\")-glucuronide.[42]\n\nThe [plasma half-life](Plasma_half-life \"Plasma half-life\") is about 35 to 40 hours when carbamazepine is given as single dose, but it is a strong [inducer](Enzyme_inducer \"Enzyme inducer\") of liver enzymes, and the plasma half-life shortens to about 12 to 17 hours when it is given repeatedly. The half-life can be further shortened to 9â€“10 hours by other enzyme inducers such as [phenytoin](Phenytoin \"Phenytoin\") or [phenobarbital](Phenobarbital \"Phenobarbital\"). About 70% are excreted via the urine, almost exclusively in form of its metabolites, and 30% via the faeces.[41][42]\n# Carbamazepine\n\n## History\n\nCarbamazepine was discovered by chemist Walter Schindler at J.R. Geigy AG (now part of [Novartis](Novartis \"Novartis\")) in [Basel](Basel \"Basel\"), [Switzerland](Switzerland \"Switzerland\"), in 1953.[43][44] It was first marketed under the brand name Tegretol in Switzerland in 1962 for [trigeminal neuralgia](Trigeminal_neuralgia \"Trigeminal neuralgia\") (formerly known as tic douloureux), and for epilepsy in 1963.[43] It has been used as an anticonvulsant and antiepileptic in the United Kingdom since 1965, and has been approved in the United States since 1968.[1]\n\nCarbamazepine was studied for bipolar disorder throughout the 1970s.[45]\n## Society and culture\n\n### Environmental impact\n\nCarbamazepine and its bio-transformation products have been detected in wastewater treatment plant effluent.[46]: 224 Field and laboratory studies have been conducted to understand the accumulation of carbamazepine in food plants grown in soil treated with [sludge](Sludge \"Sludge\"), which vary with respect to the concentrations of carbamazepine present in sludge and in the concentrations of sludge in the soil. Taking into account only studies that used concentrations commonly found in the environment, a 2015 review of pre-2015 literature concluded that \"the accumulation of carbamazepine into plants grown in soil amended with biosolids poses a _[de minimis](De_minimis#Risk_assessment \"De minimis\")_ risk to human health according to the approach.\"[46]: 227 Recent studies as of 2025 confirm the persistence of carbamazepine in surface waters, with concentrations up to 0.1 Î¼g/L reported.[](https://doi.org/10.1016/j.chemosphere.2025.141234)\n\n### Brand names\n\nCarbamazepine is available worldwide under many brand names including Tegretol.[48]\n\nPhotoswitchable analogues of carbamazepine have been developed to control its pharmacological activity locally and on demand using light (photopharmacology), with the purpose of reducing adverse systemic effects. One of these light-regulated compounds (carbadiazocine, based on a bridged azobenzene or diazocine) has been shown to produce analgesia with noninvasive illumination _in vivo_ in a rat model of neuropathic pain.[](https://doi.org/10.1002/anie.202403636)\n\nRecent studies as of 2025 have also investigated maternal exposure to environmentally relevant concentrations of carbamazepine, highlighting potential risks to fetal growth during pregnancy.[](https://pubs.acs.org/doi/10.1021/acsomega.5c04235) Additionally, research on drug interactions demonstrated that carbamazepine, as a strong CYP3A inducer, reduces exposure to zongertinib by 63.5% when coadministered.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC11823298/)\n\nA 2024 proposal to add carbamazepine to the WHO Model List of Essential Medicines for trigeminal neuralgia was not recommended for inclusion in the 2025 update.[](https://www.thelancet.com/pdfs/journals/laneur/PIIS1474-4422(25)00358-8.pdf)"])</script><script nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4">self.__next_f.push([1,"8:[\"$\",\"$L1e\",null,{\"state\":{\"mutations\":[],\"queries\":[{\"dehydratedAt\":1761886115569,\"state\":{\"data\":{\"page\":{\"citations\":[{\"id\":\"1\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ _**g**_ _**h**_ [\\\"Carbamazepine\\\"](https://www.drugs.com/monograph/carbamazepine.html). _The American Society of Health-System Pharmacists_. [Archived](https://web.archive.org/web/20150227213125/http://www.drugs.com/monograph/carbamazepine.html) from the original on 27 February 2015. Retrieved 28 March 2015.\",\"description\":\"1. ^ _**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ _**g**_ _**h**_ [\\\"Carbamazepine\\\"](https://www.drugs.com/monograph/carbamazepine.html). _The American Society of Health-System Pharmacists_. [Archived](https://web.archive.org/web/20150227213125/http://www.drugs.com/monograph/carbamazepine.html) from the original on 27 February 2015. Retrieved 28 March 2015.\",\"url\":\"https://www.drugs.com/monograph/carbamazepine.html\",\"favicon\":\"\"},{\"id\":\"2\",\"title\":\"** [Anvisa](Brazilian_Health_Regulatory_Agency \\\"Brazilian Health Regulatory Agency\\\") (31 March 2023). [\\\"RDC NÂº 784 - Listas de SubstÃ¢ncias Entorpecentes, PsicotrÃ³picas, Precursoras e Outras sob Controle Especial\\\"](https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992) [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). [DiÃ¡rio Oficial da UniÃ£o](Di%C3%A1rio_Oficial_da_Uni%C3%A3o \\\"DiÃ¡rio Oficial da UniÃ£o\\\") (published 4 April 2023). [Archived](https://web.archive.org/web/20230803143925/https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992) from the original on 3 August 2023. Retrieved 16 August 2023.\",\"description\":\"2. **^** [Anvisa](Brazilian_Health_Regulatory_Agency \\\"Brazilian Health Regulatory Agency\\\") (31 March 2023). [\\\"RDC NÂº 784 - Listas de SubstÃ¢ncias Entorpecentes, PsicotrÃ³picas, Precursoras e Outras sob Controle Especial\\\"](https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992) [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). [DiÃ¡rio Oficial da UniÃ£o](Di%C3%A1rio_Oficial_da_Uni%C3%A3o \\\"DiÃ¡rio Oficial da UniÃ£o\\\") (published 4 April 2023). [Archived](https://web.archive.org/web/20230803143925/https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992) from the original on 3 August 2023. Retrieved 16 August 2023.\",\"url\":\"Brazilian_Health_Regulatory_Agency \\\"Brazilian Health Regulatory Agency\\\"\",\"favicon\":\"\"},{\"id\":\"3\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ [\\\"Tegretol- carbamazepine suspension Tegretol- carbamazepine tablet Tegretol XR- carbamazepine tablet, extended release\\\"](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8d409411-aa9f-4f3a-a52c-fbcb0c3ec053). _DailyMed_. 16 May 2022. Retrieved 3 January 2023.\",\"description\":\"3. ^ _**a**_ _**b**_ _**c**_ _**d**_ [\\\"Tegretol- carbamazepine suspension Tegretol- carbamazepine tablet Tegretol XR- carbamazepine tablet, extended release\\\"](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8d409411-aa9f-4f3a-a52c-fbcb0c3ec053). _DailyMed_. 16 May 2022. Retrieved 3 January 2023.\",\"url\":\"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8d409411-aa9f-4f3a-a52c-fbcb0c3ec053\",\"favicon\":\"\"},{\"id\":\"4\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ _**g**_ _**h**_ _**i**_ _**j**_ _**k**_ _**l**_ _**m**_ _**n**_ _**o**_ [\\\"Carbamazepine Drug Label\\\"](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7a1e523a-b377-43dc-b231-7591c4c888ea). [Archived](https://web.archive.org/web/20141208063739/http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7a1e523a-b377-43dc-b231-7591c4c888ea) from the original on 8 December 2014.\",\"description\":\"4. ^ _**a**_ _**b**_ _**c**_ _**d**_ _**e**_ _**f**_ _**g**_ _**h**_ _**i**_ _**j**_ _**k**_ _**l**_ _**m**_ _**n**_ _**o**_ [\\\"Carbamazepine Drug Label\\\"](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7a1e523a-b377-43dc-b231-7591c4c888ea). [Archived](https://web.archive.org/web/20141208063739/http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7a1e523a-b377-43dc-b231-7591c4c888ea) from the original on 8 December 2014.\",\"url\":\"https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7a1e523a-b377-43dc-b231-7591c4c888ea\",\"favicon\":\"\"},{\"id\":\"5\",\"title\":\"** Nevitt SJ, Marson AG, Weston J, Tudur Smith C (August 2018). [\\\"Sodium valproate versus phenytoin monotherapy for epilepsy: an individual participant data review\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513104). _The Cochrane Database of Systematic Reviews_. **2018** (8): CD001769. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/14651858.CD001769.pub4](https://doi.org/10.1002%2F14651858.CD001769.pub4). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6513104](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513104). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30091458](https://pubmed.ncbi.nlm.nih.gov/30091458).\",\"description\":\"5. **^** Nevitt SJ, Marson AG, Weston J, Tudur Smith C (August 2018). [\\\"Sodium valproate versus phenytoin monotherapy for epilepsy: an individual participant data review\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513104). _The Cochrane Database of Systematic Reviews_. **2018** (8): CD001769. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/14651858.CD001769.pub4](https://doi.org/10.1002%2F14651858.CD001769.pub4). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6513104](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513104). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30091458](https://pubmed.ncbi.nlm.nih.gov/30091458).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513104\",\"favicon\":\"\"},{\"id\":\"6\",\"title\":\"_**a**_ _**b**_ Nevitt SJ, Marson AG, Tudur Smith C (July 2019). [\\\"Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637502). _The Cochrane Database of Systematic Reviews_. **2019** (7): CD001911. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/14651858.CD001911.pub4](https://doi.org/10.1002%2F14651858.CD001911.pub4). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6637502](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637502). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [31318037](https://pubmed.ncbi.nlm.nih.gov/31318037).\",\"description\":\"6. ^ _**a**_ _**b**_ Nevitt SJ, Marson AG, Tudur Smith C (July 2019). [\\\"Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637502). _The Cochrane Database of Systematic Reviews_. **2019** (7): CD001911. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/14651858.CD001911.pub4](https://doi.org/10.1002%2F14651858.CD001911.pub4). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6637502](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637502). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [31318037](https://pubmed.ncbi.nlm.nih.gov/31318037).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637502\",\"favicon\":\"\"},{\"id\":\"7\",\"title\":\"** Smith HS (2009). [_Current therapy in pain_](https://books.google.com/books?id=iTgy62MWnK4C\u0026pg=PA460). Philadelphia: Saunders/Elsevier. p. 460\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-1-4160-4836-7. [Archived](https://web.archive.org/web/20160305032812/https://books.google.ca/books?id=iTgy62MWnK4C\u0026pg=PA460) from the original on 5 March 2016.\",\"description\":\"7. **^** Smith HS (2009). [_Current therapy in pain_](https://books.google.com/books?id=iTgy62MWnK4C\u0026pg=PA460). Philadelphia: Saunders/Elsevier. p. 460\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-1-4160-4836-7. [Archived](https://web.archive.org/web/20160305032812/https://books.google.ca/books?id=iTgy62MWnK4C\u0026pg=PA460) from the original on 5 March 2016.\",\"url\":\"https://books.google.com/books?id=iTgy62MWnK4C\u0026pg=PA460\",\"favicon\":\"\"},{\"id\":\"8\",\"title\":\"** [US patent 2948718](https://worldwide.espacenet.com/patent/search/family/003449474/publication/US2948718A?q=US2948718A), Walter Schindler, \\\"New n-heterocyclic compounds\\\", published 9 August 1960, issued 9 August 1960, assigned to Geigy Chemical Corporation\",\"description\":\"8. **^** [US patent 2948718](https://worldwide.espacenet.com/patent/search/family/003449474/publication/US2948718A?q=US2948718A), Walter Schindler, \\\"New n-heterocyclic compounds\\\", published 9 August 1960, issued 9 August 1960, assigned to Geigy Chemical Corporation\",\"url\":\"https://worldwide.espacenet.com/patent/search/family/003449474/publication/US2948718A?q=US2948718A\",\"favicon\":\"\"},{\"id\":\"9\",\"title\":\"** MoshÃ© S (2009). [_The treatment of epilepsy_](https://books.google.com/books?id=rFFzFzZJtasC\u0026pg=PR29) (3 ed.). Chichester, UK: Wiley-Blackwell. p. xxix. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-1-4443-1667-4. [Archived](https://web.archive.org/web/20160305024852/https://books.google.ca/books?id=rFFzFzZJtasC\u0026pg=PR29) from the original on 5 March 2016.\",\"description\":\"9. **^** MoshÃ© S (2009). [_The treatment of epilepsy_](https://books.google.com/books?id=rFFzFzZJtasC\u0026pg=PR29) (3 ed.). Chichester, UK: Wiley-Blackwell. p. xxix. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-1-4443-1667-4. [Archived](https://web.archive.org/web/20160305024852/https://books.google.ca/books?id=rFFzFzZJtasC\u0026pg=PR29) from the original on 5 March 2016.\",\"url\":\"https://books.google.com/books?id=rFFzFzZJtasC\u0026pg=PR29\",\"favicon\":\"\"},{\"id\":\"10\",\"title\":\"** Porter NC (2008). [\\\"Trigeminal Neuralgia: Surgical Perspective\\\"](https://books.google.com/books?id=uEghr21XY6wC\u0026pg=PA536). In Chin LS, Regine WF (eds.). _Principles and practice of stereotactic radiosurgery_. New York: Springer. p. 536\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-0-387-71070-9. [Archived](https://web.archive.org/web/20160305021147/https://books.google.ca/books?id=uEghr21XY6wC\u0026pg=PA536) from the original on 5 March 2016.\",\"description\":\"10. **^** Porter NC (2008). [\\\"Trigeminal Neuralgia: Surgical Perspective\\\"](https://books.google.com/books?id=uEghr21XY6wC\u0026pg=PA536). In Chin LS, Regine WF (eds.). _Principles and practice of stereotactic radiosurgery_. New York: Springer. p. 536\\\\. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-0-387-71070-9. [Archived](https://web.archive.org/web/20160305021147/https://books.google.ca/books?id=uEghr21XY6wC\u0026pg=PA536) from the original on 5 March 2016.\",\"url\":\"https://books.google.com/books?id=uEghr21XY6wC\u0026pg=PA536\",\"favicon\":\"\"},{\"id\":\"11\",\"title\":\"** Organization WH (2019). _World Health Organization model list of essential medicines: 21st list 2019_. Geneva: [World Health Organization](World_Health_Organization \\\"World Health Organization\\\"). [hdl](Hdl_\\\\(identifier\\\\) \\\"Hdl \\\\(identifier\\\\)\\\"):[10665/325771](https://hdl.handle.net/10665%2F325771). WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.\",\"description\":\"11. **^** Organization WH (2019). _World Health Organization model list of essential medicines: 21st list 2019_. Geneva: [World Health Organization](World_Health_Organization \\\"World Health Organization\\\"). [hdl](Hdl_\\\\(identifier\\\\) \\\"Hdl \\\\(identifier\\\\)\\\"):[10665/325771](https://hdl.handle.net/10665%2F325771). WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.\",\"url\":\"World_Health_Organization \\\"World Health Organization\\\"\",\"favicon\":\"\"},{\"id\":\"12\",\"title\":\"** [\\\"Top 300 of 2023\\\"](https://clincalc.com/DrugStats/Top300Drugs.aspx). _ClinCalc_. [Archived](https://web.archive.org/web/20250812130026/https://clincalc.com/DrugStats/Top300Drugs.aspx) from the original on 12 August 2025. Retrieved 12 August 2025.\",\"description\":\"12. **^** [\\\"Top 300 of 2023\\\"](https://clincalc.com/DrugStats/Top300Drugs.aspx). _ClinCalc_. [Archived](https://web.archive.org/web/20250812130026/https://clincalc.com/DrugStats/Top300Drugs.aspx) from the original on 12 August 2025. Retrieved 12 August 2025.\",\"url\":\"https://clincalc.com/DrugStats/Top300Drugs.aspx\",\"favicon\":\"\"},{\"id\":\"13\",\"title\":\"** [\\\"Carbamazepine - Drug Usage Statistics\\\"](https://clincalc.com/DrugStats/Drugs/Carbamazepine). _ClinCalc_. Retrieved 19 August 2025.\",\"description\":\"13. **^** [\\\"Carbamazepine - Drug Usage Statistics\\\"](https://clincalc.com/DrugStats/Drugs/Carbamazepine). _ClinCalc_. Retrieved 19 August 2025.\",\"url\":\"https://clincalc.com/DrugStats/Drugs/Carbamazepine\",\"favicon\":\"\"},{\"id\":\"14\",\"title\":\"** Camerin L, Maleeva G, Gomila-Juaneda A, SuÃ¡rez-Pereira I, Matera C, Prischich D, et al. (June 2024). [\\\"Photoswitchable carbamazepine analogs for non-invasive neuroinhibition in vivo\\\"](https://doi.org/10.1002%2Fanie.202403636). _Angewandte Chemie_. **63** (38) e202403636. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2024ACIE...63E3636C](https://ui.adsabs.harvard.edu/abs/2024ACIE...63E3636C). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/anie.202403636](https://doi.org/10.1002%2Fanie.202403636). [hdl](Hdl_\\\\(identifier\\\\) \\\"Hdl \\\\(identifier\\\\)\\\"):[2445/215169](https://hdl.handle.net/2445%2F215169). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [38887153](https://pubmed.ncbi.nlm.nih.gov/38887153).\",\"description\":\"14. **^** Camerin L, Maleeva G, Gomila-Juaneda A, SuÃ¡rez-Pereira I, Matera C, Prischich D, et al. (June 2024). [\\\"Photoswitchable carbamazepine analogs for non-invasive neuroinhibition in vivo\\\"](https://doi.org/10.1002%2Fanie.202403636). _Angewandte Chemie_. **63** (38) e202403636. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2024ACIE...63E3636C](https://ui.adsabs.harvard.edu/abs/2024ACIE...63E3636C). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/anie.202403636](https://doi.org/10.1002%2Fanie.202403636). [hdl](Hdl_\\\\(identifier\\\\) \\\"Hdl \\\\(identifier\\\\)\\\"):[2445/215169](https://hdl.handle.net/2445%2F215169). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [38887153](https://pubmed.ncbi.nlm.nih.gov/38887153).\",\"url\":\"https://doi.org/10.1002%2Fanie.202403636\",\"favicon\":\"\"},{\"id\":\"15\",\"title\":\"** Ceron-Litvoc D, Soares BG, Geddes J, Litvoc J, de Lima MS (January 2009). \\\"Comparison of carbamazepine and lithium in treatment of bipolar disorder: a systematic review of randomized controlled trials\\\". _Human Psychopharmacology_. **24** (1): 19â€“28\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/hup.990](https://doi.org/10.1002%2Fhup.990). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [19053079](https://pubmed.ncbi.nlm.nih.gov/19053079). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [5684931](https://api.semanticscholar.org/CorpusID:5684931).\",\"description\":\"15. **^** Ceron-Litvoc D, Soares BG, Geddes J, Litvoc J, de Lima MS (January 2009). \\\"Comparison of carbamazepine and lithium in treatment of bipolar disorder: a systematic review of randomized controlled trials\\\". _Human Psychopharmacology_. **24** (1): 19â€“28\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/hup.990](https://doi.org/10.1002%2Fhup.990). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [19053079](https://pubmed.ncbi.nlm.nih.gov/19053079). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [5684931](https://api.semanticscholar.org/CorpusID:5684931).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"16\",\"title\":\"** Leucht S, Helfer B, Dold M, Kissling W, McGrath J, et al. (Cochrane Schizophrenia Group) (May 2014). [\\\"Carbamazepine for schizophrenia\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032545). _The Cochrane Database of Systematic Reviews_. **2014** (5): CD001258. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/14651858.CD001258.pub3](https://doi.org/10.1002%2F14651858.CD001258.pub3). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [7032545](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032545). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [24789267](https://pubmed.ncbi.nlm.nih.gov/24789267).\",\"description\":\"16. **^** Leucht S, Helfer B, Dold M, Kissling W, McGrath J, et al. (Cochrane Schizophrenia Group) (May 2014). [\\\"Carbamazepine for schizophrenia\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032545). _The Cochrane Database of Systematic Reviews_. **2014** (5): CD001258. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/14651858.CD001258.pub3](https://doi.org/10.1002%2F14651858.CD001258.pub3). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [7032545](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032545). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [24789267](https://pubmed.ncbi.nlm.nih.gov/24789267).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7032545\",\"favicon\":\"\"},{\"id\":\"17\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ _**e**_ Lexi-Comp (February 2009). [\\\"Carbamazepine\\\"](http://www.merck.com/mmpe/lexicomp/carbamazepine.html). _[The Merck Manual Professional](Merck_Manual_of_Diagnosis_and_Therapy \\\"Merck Manual of Diagnosis and Therapy\\\")_. [Archived](https://web.archive.org/web/20101103035532/http://www.merck.com/mmpe/lexicomp/carbamazepine.html) from the original on 3 November 2010. Retrieved on 3 May 2009.\",\"description\":\"17. ^ _**a**_ _**b**_ _**c**_ _**d**_ _**e**_ Lexi-Comp (February 2009). [\\\"Carbamazepine\\\"](http://www.merck.com/mmpe/lexicomp/carbamazepine.html). _[The Merck Manual Professional](Merck_Manual_of_Diagnosis_and_Therapy \\\"Merck Manual of Diagnosis and Therapy\\\")_. [Archived](https://web.archive.org/web/20101103035532/http://www.merck.com/mmpe/lexicomp/carbamazepine.html) from the original on 3 November 2010. Retrieved on 3 May 2009.\",\"url\":\"http://www.merck.com/mmpe/lexicomp/carbamazepine.html\",\"favicon\":\"\"},{\"id\":\"18\",\"title\":\"** Pino MA (19 January 2017). [\\\"Trigeminal Neuralgia: A \\\"Lightning Bolt\\\" of Pain\\\"](https://www.uspharmacist.com/article/trigeminal-neuralgia-a-lightning-bolt-of-pain). _US Pharmacist_. **42** : 41â€“44.\",\"description\":\"18. **^** Pino MA (19 January 2017). [\\\"Trigeminal Neuralgia: A \\\"Lightning Bolt\\\" of Pain\\\"](https://www.uspharmacist.com/article/trigeminal-neuralgia-a-lightning-bolt-of-pain). _US Pharmacist_. **42** : 41â€“44.\",\"url\":\"https://www.uspharmacist.com/article/trigeminal-neuralgia-a-lightning-bolt-of-pain\",\"favicon\":\"\"},{\"id\":\"19\",\"title\":\"** Powell G, Saunders M, Rigby A, Marson AG (December 2016). [\\\"Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463840). _The Cochrane Database of Systematic Reviews_. **12** (4): CD007124. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/14651858.CD007124.pub5](https://doi.org/10.1002%2F14651858.CD007124.pub5). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6463840](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463840). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [27933615](https://pubmed.ncbi.nlm.nih.gov/27933615).\",\"description\":\"19. **^** Powell G, Saunders M, Rigby A, Marson AG (December 2016). [\\\"Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463840). _The Cochrane Database of Systematic Reviews_. **12** (4): CD007124. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/14651858.CD007124.pub5](https://doi.org/10.1002%2F14651858.CD007124.pub5). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6463840](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463840). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [27933615](https://pubmed.ncbi.nlm.nih.gov/27933615).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463840\",\"favicon\":\"\"},{\"id\":\"20\",\"title\":\"** Sunwoo, W., Jeon, Y., Bae, Y. et al. Typewriter tinnitus revisited: The typical symptoms and the initial response to carbamazepine are the most reliable diagnostic clues. Sci Rep 7, 10615 (2017). \u003chttps://doi.org/10.1038/s41598-017-10798-w\u003e\",\"description\":\"20. **^** Sunwoo, W., Jeon, Y., Bae, Y. et al. Typewriter tinnitus revisited: The typical symptoms and the initial response to carbamazepine are the most reliable diagnostic clues. Sci Rep 7, 10615 (2017). \u003chttps://doi.org/10.1038/s41598-017-10798-w\u003e\",\"url\":\"https://doi.org/10.1038/s41598-017-10798-w\u003e\",\"favicon\":\"\"},{\"id\":\"21\",\"title\":\"** Vukovic Cvetkovic V, Jensen RH (January 2019). [\\\"Neurostimulation for the treatment of chronic migraine and cluster headache\\\"](https://doi.org/10.1111%2Fane.13034). _Acta Neurologica Scandinavica_. **139** (1): 4â€“17\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/ane.13034](https://doi.org/10.1111%2Fane.13034). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30291633](https://pubmed.ncbi.nlm.nih.gov/30291633). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [52923061](https://api.semanticscholar.org/CorpusID:52923061).\",\"description\":\"21. **^** Vukovic Cvetkovic V, Jensen RH (January 2019). [\\\"Neurostimulation for the treatment of chronic migraine and cluster headache\\\"](https://doi.org/10.1111%2Fane.13034). _Acta Neurologica Scandinavica_. **139** (1): 4â€“17\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/ane.13034](https://doi.org/10.1111%2Fane.13034). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30291633](https://pubmed.ncbi.nlm.nih.gov/30291633). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [52923061](https://api.semanticscholar.org/CorpusID:52923061).\",\"url\":\"https://doi.org/10.1111%2Fane.13034\",\"favicon\":\"\"},{\"id\":\"22\",\"title\":\"** Gandelman MS (March 1994). \\\"Review of carbamazepine-induced hyponatremia\\\". _Progress in Neuro-Psychopharmacology \u0026 Biological Psychiatry_. **18** (2): 211â€“33\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/0278-5846(94)90055-8](https://doi.org/10.1016%2F0278-5846%2894%2990055-8). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [8208974](https://pubmed.ncbi.nlm.nih.gov/8208974). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [36758508](https://api.semanticscholar.org/CorpusID:36758508).\",\"description\":\"22. **^** Gandelman MS (March 1994). \\\"Review of carbamazepine-induced hyponatremia\\\". _Progress in Neuro-Psychopharmacology \u0026 Biological Psychiatry_. **18** (2): 211â€“33\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/0278-5846(94)90055-8](https://doi.org/10.1016%2F0278-5846%2894%2990055-8). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [8208974](https://pubmed.ncbi.nlm.nih.gov/8208974). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [36758508](https://api.semanticscholar.org/CorpusID:36758508).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"23\",\"title\":\"** Jentink J, Dolk H, Loane MA, Morris JK, Wellesley D, Garne E, et al. (December 2010). [\\\"Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996546). _BMJ_. **341** : c6581. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1136/bmj.c6581](https://doi.org/10.1136%2Fbmj.c6581). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2996546](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996546). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21127116](https://pubmed.ncbi.nlm.nih.gov/21127116).\",\"description\":\"23. **^** Jentink J, Dolk H, Loane MA, Morris JK, Wellesley D, Garne E, et al. (December 2010). [\\\"Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996546). _BMJ_. **341** : c6581. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1136/bmj.c6581](https://doi.org/10.1136%2Fbmj.c6581). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [2996546](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996546). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [21127116](https://pubmed.ncbi.nlm.nih.gov/21127116).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996546\",\"favicon\":\"\"},{\"id\":\"24\",\"title\":\"** Liu L, Zheng T, Morris MJ, Wallengren C, Clarke AL, Reid CA, et al. (November 2006). \\\"The mechanism of carbamazepine aggravation of absence seizures\\\". _The Journal of Pharmacology and Experimental Therapeutics_. **319** (2): 790â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1124/jpet.106.104968](https://doi.org/10.1124%2Fjpet.106.104968). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16895979](https://pubmed.ncbi.nlm.nih.gov/16895979). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [7693614](https://api.semanticscholar.org/CorpusID:7693614).\",\"description\":\"24. **^** Liu L, Zheng T, Morris MJ, Wallengren C, Clarke AL, Reid CA, et al. (November 2006). \\\"The mechanism of carbamazepine aggravation of absence seizures\\\". _The Journal of Pharmacology and Experimental Therapeutics_. **319** (2): 790â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1124/jpet.106.104968](https://doi.org/10.1124%2Fjpet.106.104968). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16895979](https://pubmed.ncbi.nlm.nih.gov/16895979). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [7693614](https://api.semanticscholar.org/CorpusID:7693614).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"25\",\"title\":\"** Tateno A, Sawada K, Takahashi I, Hujiwara Y (August 2006). \\\"Carbamazepine-induced transient auditory pitch-perception deficit\\\". _Pediatric Neurology_. **35** (2): 131â€“4\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.pediatrneurol.2006.01.011](https://doi.org/10.1016%2Fj.pediatrneurol.2006.01.011). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16876011](https://pubmed.ncbi.nlm.nih.gov/16876011).\",\"description\":\"25. **^** Tateno A, Sawada K, Takahashi I, Hujiwara Y (August 2006). \\\"Carbamazepine-induced transient auditory pitch-perception deficit\\\". _Pediatric Neurology_. **35** (2): 131â€“4\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.pediatrneurol.2006.01.011](https://doi.org/10.1016%2Fj.pediatrneurol.2006.01.011). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [16876011](https://pubmed.ncbi.nlm.nih.gov/16876011).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"26\",\"title\":\"** Kaniwa N, Saito Y (June 2013). [\\\"Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury\\\"](https://doi.org/10.1038%2Fjhg.2013.37). _Journal of Human Genetics_. **58** (6): 317â€“26\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/jhg.2013.37](https://doi.org/10.1038%2Fjhg.2013.37). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23635947](https://pubmed.ncbi.nlm.nih.gov/23635947).\",\"description\":\"26. **^** Kaniwa N, Saito Y (June 2013). [\\\"Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury\\\"](https://doi.org/10.1038%2Fjhg.2013.37). _Journal of Human Genetics_. **58** (6): 317â€“26\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/jhg.2013.37](https://doi.org/10.1038%2Fjhg.2013.37). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23635947](https://pubmed.ncbi.nlm.nih.gov/23635947).\",\"url\":\"https://doi.org/10.1038%2Fjhg.2013.37\",\"favicon\":\"\"},{\"id\":\"27\",\"title\":\"_**a**_ _**b**_ Amstutz U, Shear NH, Rieder MJ, Hwang S, Fung V, Nakamura H, et al. (April 2014). \\\"Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions\\\". _Epilepsia_. **55** (4): 496â€“506\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/epi.12564](https://doi.org/10.1111%2Fepi.12564). [hdl](Hdl_\\\\(identifier\\\\) \\\"Hdl \\\\(identifier\\\\)\\\"):[2429/63109](https://hdl.handle.net/2429%2F63109). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [24597466](https://pubmed.ncbi.nlm.nih.gov/24597466). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [41565230](https://api.semanticscholar.org/CorpusID:41565230).\",\"description\":\"27. ^ _**a**_ _**b**_ Amstutz U, Shear NH, Rieder MJ, Hwang S, Fung V, Nakamura H, et al. (April 2014). \\\"Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions\\\". _Epilepsia_. **55** (4): 496â€“506\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/epi.12564](https://doi.org/10.1111%2Fepi.12564). [hdl](Hdl_\\\\(identifier\\\\) \\\"Hdl \\\\(identifier\\\\)\\\"):[2429/63109](https://hdl.handle.net/2429%2F63109). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [24597466](https://pubmed.ncbi.nlm.nih.gov/24597466). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [41565230](https://api.semanticscholar.org/CorpusID:41565230).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"28\",\"title\":\"** Leckband SG, Kelsoe JR, Dunnenberger HM, George AL, Tran E, Berger R, et al. (September 2013). [\\\"Clinical Pharmacogenetics Implementation Consortium guidelines for HLA-B genotype and carbamazepine dosing\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3748365). _Clinical Pharmacology and Therapeutics_. **94** (3): 324â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/clpt.2013.103](https://doi.org/10.1038%2Fclpt.2013.103). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3748365](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3748365). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23695185](https://pubmed.ncbi.nlm.nih.gov/23695185).\",\"description\":\"28. **^** Leckband SG, Kelsoe JR, Dunnenberger HM, George AL, Tran E, Berger R, et al. (September 2013). [\\\"Clinical Pharmacogenetics Implementation Consortium guidelines for HLA-B genotype and carbamazepine dosing\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3748365). _Clinical Pharmacology and Therapeutics_. **94** (3): 324â€“8\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/clpt.2013.103](https://doi.org/10.1038%2Fclpt.2013.103). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [3748365](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3748365). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [23695185](https://pubmed.ncbi.nlm.nih.gov/23695185).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3748365\",\"favicon\":\"\"},{\"id\":\"29\",\"title\":\"** Garon SL, Pavlos RK, White KD, Brown NJ, Stone CA, Phillips EJ (September 2017). [\\\"Pharmacogenomics of off-target adverse drug reactions\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555876). _British Journal of Clinical Pharmacology_. **83** (9): 1896â€“1911\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/bcp.13294](https://doi.org/10.1111%2Fbcp.13294). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5555876](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555876). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [28345177](https://pubmed.ncbi.nlm.nih.gov/28345177).\",\"description\":\"29. **^** Garon SL, Pavlos RK, White KD, Brown NJ, Stone CA, Phillips EJ (September 2017). [\\\"Pharmacogenomics of off-target adverse drug reactions\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555876). _British Journal of Clinical Pharmacology_. **83** (9): 1896â€“1911\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/bcp.13294](https://doi.org/10.1111%2Fbcp.13294). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5555876](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555876). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [28345177](https://pubmed.ncbi.nlm.nih.gov/28345177).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555876\",\"favicon\":\"\"},{\"id\":\"30\",\"title\":\"** Jaruthamsophon K, Tipmanee V, Sangiemchoey A, Sukasem C, Limprasert P (March 2017). [\\\"HLA-B*15:21 and carbamazepine-induced Stevens-Johnson syndrome: pooled-data and in silico analysis\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372085). _Scientific Reports_. **7** (1) 45553. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2017NatSR...745553J](https://ui.adsabs.harvard.edu/abs/2017NatSR...745553J). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/srep45553](https://doi.org/10.1038%2Fsrep45553). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5372085](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372085). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [28358139](https://pubmed.ncbi.nlm.nih.gov/28358139).\",\"description\":\"30. **^** Jaruthamsophon K, Tipmanee V, Sangiemchoey A, Sukasem C, Limprasert P (March 2017). [\\\"HLA-B*15:21 and carbamazepine-induced Stevens-Johnson syndrome: pooled-data and in silico analysis\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372085). _Scientific Reports_. **7** (1) 45553. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2017NatSR...745553J](https://ui.adsabs.harvard.edu/abs/2017NatSR...745553J). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/srep45553](https://doi.org/10.1038%2Fsrep45553). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [5372085](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372085). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [28358139](https://pubmed.ncbi.nlm.nih.gov/28358139).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372085\",\"favicon\":\"\"},{\"id\":\"31\",\"title\":\"** Stafstrom CE, Nohria V, Loganbill H, Nahouraii R, Boustany RM, DeLong GR (January 1995). [\\\"Erythromycin-induced carbamazepine toxicity: a continuing problem\\\"](http://archpedi.ama-assn.org/cgi/pmidlookup?view=long\u0026pmid=7827672). _Archives of Pediatrics \u0026 Adolescent Medicine_. **149** (1): 99â€“101\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1001/archpedi.1995.02170130101025](https://doi.org/10.1001%2Farchpedi.1995.02170130101025). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [7827672](https://pubmed.ncbi.nlm.nih.gov/7827672). [Archived](https://archive.today/20240525023120/https://www.webcitation.org/5uKvQB98w?url=http://archpedi.ama-assn.org/cgi/pmidlookup%3Fview=long\u0026pmid=7827672) from the original on 25 May 2024.\",\"description\":\"31. **^** Stafstrom CE, Nohria V, Loganbill H, Nahouraii R, Boustany RM, DeLong GR (January 1995). [\\\"Erythromycin-induced carbamazepine toxicity: a continuing problem\\\"](http://archpedi.ama-assn.org/cgi/pmidlookup?view=long\u0026pmid=7827672). _Archives of Pediatrics \u0026 Adolescent Medicine_. **149** (1): 99â€“101\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1001/archpedi.1995.02170130101025](https://doi.org/10.1001%2Farchpedi.1995.02170130101025). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [7827672](https://pubmed.ncbi.nlm.nih.gov/7827672). [Archived](https://archive.today/20240525023120/https://www.webcitation.org/5uKvQB98w?url=http://archpedi.ama-assn.org/cgi/pmidlookup%3Fview=long\u0026pmid=7827672) from the original on 25 May 2024.\",\"url\":\"http://archpedi.ama-assn.org/cgi/pmidlookup?view=long\u0026pmid=7827672\",\"favicon\":\"\"},{\"id\":\"32\",\"title\":\"_**a**_ _**b**_ [\\\"Carbamazepine Toxicity\\\"](http://www.emedicine.com/emerg/topic77.htm). _eMedicine_. 2 February 2019. [Archived](https://web.archive.org/web/20080704144842/http://emedicine.com/emerg/topic77.htm) from the original on 4 July 2008.\",\"description\":\"32. ^ _**a**_ _**b**_ [\\\"Carbamazepine Toxicity\\\"](http://www.emedicine.com/emerg/topic77.htm). _eMedicine_. 2 February 2019. [Archived](https://web.archive.org/web/20080704144842/http://emedicine.com/emerg/topic77.htm) from the original on 4 July 2008.\",\"url\":\"http://www.emedicine.com/emerg/topic77.htm\",\"favicon\":\"\"},{\"id\":\"33\",\"title\":\"** Gonzalez FJ, Tukey RH (2006). \\\"Drug Metabolism\\\". In Brunton L, Lazo J, Parker K (eds.). [_Goodman \u0026 Gilman's The Pharmacological Basis of Therapeutics_](Goodman_%26_Gilman's_The_Pharmacological_Basis_of_Therapeutics \\\"Goodman \u0026 Gilman's The Pharmacological Basis of Therapeutics\\\") (11th ed.). New York: [McGraw-Hill](McGraw-Hill \\\"McGraw-Hill\\\"). p. [79](https://archive.org/details/goodmangilmansph00brun_116/page/n104). [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-0-07-142280-2.\",\"description\":\"33. **^** Gonzalez FJ, Tukey RH (2006). \\\"Drug Metabolism\\\". In Brunton L, Lazo J, Parker K (eds.). [_Goodman \u0026 Gilman's The Pharmacological Basis of Therapeutics_](Goodman_%26_Gilman's_The_Pharmacological_Basis_of_Therapeutics \\\"Goodman \u0026 Gilman's The Pharmacological Basis of Therapeutics\\\") (11th ed.). New York: [McGraw-Hill](McGraw-Hill \\\"McGraw-Hill\\\"). p. [79](https://archive.org/details/goodmangilmansph00brun_116/page/n104). [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-0-07-142280-2.\",\"url\":\"Goodman_%26_Gilman's_The_Pharmacological_Basis_of_Therapeutics \\\"Goodman \u0026 Gilman's The Pharmacological Basis of Therapeutics\\\"\",\"favicon\":\"\"},{\"id\":\"34\",\"title\":\"** Moody D (2004). [\\\"Drug interactions with benzodiazepines\\\"](https://archive.org/details/handbookofdrugin0000unse/page/3). In Raymon LP, Mozayani A (eds.). _Handbook of Drug Interactions: a Clinical and Forensic Guide_. Humana. pp. [3â€“88](https://archive.org/details/handbookofdrugin0000unse/page/3). [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-1-58829-211-7.\",\"description\":\"34. **^** Moody D (2004). [\\\"Drug interactions with benzodiazepines\\\"](https://archive.org/details/handbookofdrugin0000unse/page/3). In Raymon LP, Mozayani A (eds.). _Handbook of Drug Interactions: a Clinical and Forensic Guide_. Humana. pp. [3â€“88](https://archive.org/details/handbookofdrugin0000unse/page/3). [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-1-58829-211-7.\",\"url\":\"https://archive.org/details/handbookofdrugin0000unse/page/3\",\"favicon\":\"\"},{\"id\":\"35\",\"title\":\"** Schlatter J, Madras JL, Saulnier JL, Poujade F (September 1999). \\\"[Drug interactions with methadone]\\\" [Drug interactions with methadone]. _Presse MÃ©dicale_ (in French). **28** (25): 1381â€“4\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [10506872](https://pubmed.ncbi.nlm.nih.gov/10506872).\",\"description\":\"35. **^** Schlatter J, Madras JL, Saulnier JL, Poujade F (September 1999). \\\"[Drug interactions with methadone]\\\" [Drug interactions with methadone]. _Presse MÃ©dicale_ (in French). **28** (25): 1381â€“4\\\\. [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [10506872](https://pubmed.ncbi.nlm.nih.gov/10506872).\",\"url\":\"PMID_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"36\",\"title\":\"** Rogawski MA, LÃ¶scher W, Rho JM (May 2016). [\\\"Mechanisms of Action of Antiseizure Drugs and the Ketogenic Diet\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852797). _Cold Spring Harbor Perspectives in Medicine_. **6** (5): a022780. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1101/cshperspect.a022780](https://doi.org/10.1101%2Fcshperspect.a022780). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4852797](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852797). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26801895](https://pubmed.ncbi.nlm.nih.gov/26801895).\",\"description\":\"36. **^** Rogawski MA, LÃ¶scher W, Rho JM (May 2016). [\\\"Mechanisms of Action of Antiseizure Drugs and the Ketogenic Diet\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852797). _Cold Spring Harbor Perspectives in Medicine_. **6** (5): a022780. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1101/cshperspect.a022780](https://doi.org/10.1101%2Fcshperspect.a022780). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [4852797](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852797). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [26801895](https://pubmed.ncbi.nlm.nih.gov/26801895).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852797\",\"favicon\":\"\"},{\"id\":\"37\",\"title\":\"** Dailey JW, Reith ME, Steidley KR, Milbrandt JC, Jobe PC (October 1998). [\\\"Carbamazepine-induced release of serotonin from rat hippocampus in vitro\\\"](https://doi.org/10.1111%2Fj.1528-1157.1998.tb01290.x). _Epilepsia_. **39** (10): 1054â€“63\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/j.1528-1157.1998.tb01290.x](https://doi.org/10.1111%2Fj.1528-1157.1998.tb01290.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9776325](https://pubmed.ncbi.nlm.nih.gov/9776325). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [20382623](https://api.semanticscholar.org/CorpusID:20382623).\",\"description\":\"37. **^** Dailey JW, Reith ME, Steidley KR, Milbrandt JC, Jobe PC (October 1998). [\\\"Carbamazepine-induced release of serotonin from rat hippocampus in vitro\\\"](https://doi.org/10.1111%2Fj.1528-1157.1998.tb01290.x). _Epilepsia_. **39** (10): 1054â€“63\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/j.1528-1157.1998.tb01290.x](https://doi.org/10.1111%2Fj.1528-1157.1998.tb01290.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9776325](https://pubmed.ncbi.nlm.nih.gov/9776325). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [20382623](https://api.semanticscholar.org/CorpusID:20382623).\",\"url\":\"https://doi.org/10.1111%2Fj.1528-1157.1998.tb01290.x\",\"favicon\":\"\"},{\"id\":\"38\",\"title\":\"** Dailey JW, Reith ME, Yan QS, Li MY, Jobe PC (June 1997). \\\"Carbamazepine increases extracellular serotonin concentration: lack of antagonism by tetrodotoxin or zero Ca2+\\\". _European Journal of Pharmacology_. **328** (2â€“3): 153â€“62\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/s0014-2999(97)83041-5](https://doi.org/10.1016%2Fs0014-2999%2897%2983041-5). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9218697](https://pubmed.ncbi.nlm.nih.gov/9218697).\",\"description\":\"38. **^** Dailey JW, Reith ME, Yan QS, Li MY, Jobe PC (June 1997). \\\"Carbamazepine increases extracellular serotonin concentration: lack of antagonism by tetrodotoxin or zero Ca2+\\\". _European Journal of Pharmacology_. **328** (2â€“3): 153â€“62\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/s0014-2999(97)83041-5](https://doi.org/10.1016%2Fs0014-2999%2897%2983041-5). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9218697](https://pubmed.ncbi.nlm.nih.gov/9218697).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"39\",\"title\":\"** Kawata Y, Okada M, Murakami T, Kamata A, Zhu G, Kaneko S (June 2001). [\\\"Pharmacological discrimination between effects of carbamazepine on hippocampal basal, Ca(2+)- and K(+)-evoked serotonin release\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572811). _British Journal of Pharmacology_. **133** (4): 557â€“67\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/sj.bjp.0704104](https://doi.org/10.1038%2Fsj.bjp.0704104). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1572811](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572811). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11399673](https://pubmed.ncbi.nlm.nih.gov/11399673).\",\"description\":\"39. **^** Kawata Y, Okada M, Murakami T, Kamata A, Zhu G, Kaneko S (June 2001). [\\\"Pharmacological discrimination between effects of carbamazepine on hippocampal basal, Ca(2+)- and K(+)-evoked serotonin release\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572811). _British Journal of Pharmacology_. **133** (4): 557â€“67\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1038/sj.bjp.0704104](https://doi.org/10.1038%2Fsj.bjp.0704104). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [1572811](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572811). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [11399673](https://pubmed.ncbi.nlm.nih.gov/11399673).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1572811\",\"favicon\":\"\"},{\"id\":\"40\",\"title\":\"** Gambeta E, Chichorro JG, Zamponi GW (January 2020). [\\\"Trigeminal Neuralgia: an overview from pathophysiology to pharmacological treatments\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985973). _Molecular Pain_. **16** 1744806920901890\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1177/1744806920901890](https://doi.org/10.1177%2F1744806920901890). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6985973](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985973). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [31908187](https://pubmed.ncbi.nlm.nih.gov/31908187).\",\"description\":\"40. **^** Gambeta E, Chichorro JG, Zamponi GW (January 2020). [\\\"Trigeminal Neuralgia: an overview from pathophysiology to pharmacological treatments\\\"](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985973). _Molecular Pain_. **16** 1744806920901890\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1177/1744806920901890](https://doi.org/10.1177%2F1744806920901890). [PMC](PMC_\\\\(identifier\\\\) \\\"PMC \\\\(identifier\\\\)\\\") [6985973](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985973). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [31908187](https://pubmed.ncbi.nlm.nih.gov/31908187).\",\"url\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6985973\",\"favicon\":\"\"},{\"id\":\"41\",\"title\":\"_**a**_ _**b**_ [\\\"Carbamazepine\\\"](https://pubchem.ncbi.nlm.nih.gov/compound/2554). _PubChem_. National Library of Medicine, National Institutes of Health, U.S. Department of Health and Human Services. Retrieved 6 May 2021.\",\"description\":\"41. ^ _**a**_ _**b**_ [\\\"Carbamazepine\\\"](https://pubchem.ncbi.nlm.nih.gov/compound/2554). _PubChem_. National Library of Medicine, National Institutes of Health, U.S. Department of Health and Human Services. Retrieved 6 May 2021.\",\"url\":\"https://pubchem.ncbi.nlm.nih.gov/compound/2554\",\"favicon\":\"\"},{\"id\":\"42\",\"title\":\"_**a**_ _**b**_ _**c**_ _**d**_ Haberfeld H, ed. (2021). _Austria-Codex_ (in German). Vienna: Ã–sterreichischer Apothekerverlag. Tegretol retard 400 mg-Filmtabletten.\",\"description\":\"42. ^ _**a**_ _**b**_ _**c**_ _**d**_ Haberfeld H, ed. (2021). _Austria-Codex_ (in German). Vienna: Ã–sterreichischer Apothekerverlag. Tegretol retard 400 mg-Filmtabletten.\",\"url\":\"\",\"favicon\":\"\"},{\"id\":\"43\",\"title\":\"_**a**_ _**b**_ Scott DF (1993). \\\"Chapter 8: Carbamazepine\\\". _The History of Epileptic Therapy: An Account of How Medication was Developed_. History of Medicine Series. CRC Press. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-1-85070-391-4.\",\"description\":\"43. ^ _**a**_ _**b**_ Scott DF (1993). \\\"Chapter 8: Carbamazepine\\\". _The History of Epileptic Therapy: An Account of How Medication was Developed_. History of Medicine Series. CRC Press. [ISBN](ISBN_\\\\(identifier\\\\) \\\"ISBN \\\\(identifier\\\\)\\\") 978-1-85070-391-4.\",\"url\":\"ISBN_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"44\",\"title\":\"** Schindler W, HÃ¤fliger F (1954). \\\"Ãœber Derivate des Iminodibenzyls\\\". _[Helvetica Chimica Acta](Helvetica_Chimica_Acta \\\"Helvetica Chimica Acta\\\")_. **37** (2): 472â€“83\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[1954HChAc..37..472S](https://ui.adsabs.harvard.edu/abs/1954HChAc..37..472S). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/hlca.19540370211](https://doi.org/10.1002%2Fhlca.19540370211).\",\"description\":\"44. **^** Schindler W, HÃ¤fliger F (1954). \\\"Ãœber Derivate des Iminodibenzyls\\\". _[Helvetica Chimica Acta](Helvetica_Chimica_Acta \\\"Helvetica Chimica Acta\\\")_. **37** (2): 472â€“83\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[1954HChAc..37..472S](https://ui.adsabs.harvard.edu/abs/1954HChAc..37..472S). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1002/hlca.19540370211](https://doi.org/10.1002%2Fhlca.19540370211).\",\"url\":\"Helvetica_Chimica_Acta \\\"Helvetica Chimica Acta\\\"\",\"favicon\":\"\"},{\"id\":\"45\",\"title\":\"** Okuma T, Kishimoto A (February 1998). \\\"A history of investigation on the mood stabilizing effect of carbamazepine in Japan\\\". _Psychiatry and Clinical Neurosciences_. **52** (1): 3â€“12\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/j.1440-1819.1998.tb00966.x](https://doi.org/10.1111%2Fj.1440-1819.1998.tb00966.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9682927](https://pubmed.ncbi.nlm.nih.gov/9682927). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [8480811](https://api.semanticscholar.org/CorpusID:8480811).\",\"description\":\"45. **^** Okuma T, Kishimoto A (February 1998). \\\"A history of investigation on the mood stabilizing effect of carbamazepine in Japan\\\". _Psychiatry and Clinical Neurosciences_. **52** (1): 3â€“12\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1111/j.1440-1819.1998.tb00966.x](https://doi.org/10.1111%2Fj.1440-1819.1998.tb00966.x). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [9682927](https://pubmed.ncbi.nlm.nih.gov/9682927). [S2CID](S2CID_\\\\(identifier\\\\) \\\"S2CID \\\\(identifier\\\\)\\\") [8480811](https://api.semanticscholar.org/CorpusID:8480811).\",\"url\":\"Doi_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"46\",\"title\":\"_**a**_ _**b**_ Prosser RS, Sibley PK (February 2015). \\\"Human health risk assessment of pharmaceuticals and personal care products in plant tissue due to biosolids and manure amendments, and wastewater irrigation\\\". _Environment International_. **75** : 223â€“33\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2015EnInt..75..223P](https://ui.adsabs.harvard.edu/abs/2015EnInt..75..223P). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.envint.2014.11.020](https://doi.org/10.1016%2Fj.envint.2014.11.020). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [25486094](https://pubmed.ncbi.nlm.nih.gov/25486094).\",\"description\":\"46. ^ _**a**_ _**b**_ Prosser RS, Sibley PK (February 2015). \\\"Human health risk assessment of pharmaceuticals and personal care products in plant tissue due to biosolids and manure amendments, and wastewater irrigation\\\". _Environment International_. **75** : 223â€“33\\\\. [Bibcode](Bibcode_\\\\(identifier\\\\) \\\"Bibcode \\\\(identifier\\\\)\\\"):[2015EnInt..75..223P](https://ui.adsabs.harvard.edu/abs/2015EnInt..75..223P). [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1016/j.envint.2014.11.020](https://doi.org/10.1016%2Fj.envint.2014.11.020). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [25486094](https://pubmed.ncbi.nlm.nih.gov/25486094).\",\"url\":\"Bibcode_\\\\(identifier\\\\\",\"favicon\":\"\"},{\"id\":\"47\",\"title\":\"** Posselt M, Jaeger A, Schaper JL, Radke M, Benskin JP (December 2018). [\\\"Determination of polar organic micropollutants in surface and pore water by high-resolution sampling-direct injection-ultra high performance liquid chromatography-tandem mass spectrometry\\\"](https://doi.org/10.1039%2FC8EM00390D). _Environmental Science: Processes \u0026 Impacts_. **20** (12): 1716â€“1727\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1039/C8EM00390D](https://doi.org/10.1039%2FC8EM00390D). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30350841](https://pubmed.ncbi.nlm.nih.gov/30350841).\",\"description\":\"47. **^** Posselt M, Jaeger A, Schaper JL, Radke M, Benskin JP (December 2018). [\\\"Determination of polar organic micropollutants in surface and pore water by high-resolution sampling-direct injection-ultra high performance liquid chromatography-tandem mass spectrometry\\\"](https://doi.org/10.1039%2FC8EM00390D). _Environmental Science: Processes \u0026 Impacts_. **20** (12): 1716â€“1727\\\\. [doi](Doi_\\\\(identifier\\\\) \\\"Doi \\\\(identifier\\\\)\\\"):[10.1039/C8EM00390D](https://doi.org/10.1039%2FC8EM00390D). [PMID](PMID_\\\\(identifier\\\\) \\\"PMID \\\\(identifier\\\\)\\\") [30350841](https://pubmed.ncbi.nlm.nih.gov/30350841).\",\"url\":\"https://doi.org/10.1039%2FC8EM00390D\",\"favicon\":\"\"},{\"id\":\"48\",\"title\":\"** [\\\"Carbamazepine\\\"](https://www.drugs.com/international/carbamazepine.html). _Drugs.com_. Retrieved 27 October 2019.\",\"description\":\"48. **^** [\\\"Carbamazepine\\\"](https://www.drugs.com/international/carbamazepine.html). _Drugs.com_. Retrieved 27 October 2019.\",\"url\":\"https://www.drugs.com/international/carbamazepine.html\",\"favicon\":\"\"}],\"images\":[],\"fixedIssues\":[{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"It is used as an adjunctive treatment in schizophrenia along with other medications and as a second-line agent in bipolar disorder.[5][1]\",\"explanation\":\"Reference [5] discusses sodium valproate versus phenytoin for epilepsy and does not support claims regarding schizophrenia or bipolar disorder, leading to inaccurate sourcing.\",\"fixedText\":\"Replace [5][1] with [1][15][16] to correctly source the claims.\",\"evidenceSource\":\"[1] (ASHP monograph supports both uses); [15] (systematic review for bipolar); [16] (Cochrane review for schizophrenia)\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"Carbamazepine appears to work as well as phenytoin and valproate for focal and generalized seizures.[6]\",\"explanation\":\"Reference [6] only compares carbamazepine to phenytoin monotherapy for epilepsy and does not address valproate, making the citation incomplete for the full claim.\",\"fixedText\":\"Add citation for valproate comparison: change to [6][Cochrane valproate URL].\",\"evidenceSource\":\"[6] (for phenytoin comparison); [](https://doi.org/10.1002/14651858.CD001388.pub3) (Cochrane review for carbamazepine vs. valproate monotherapy, finding no important difference in efficacy)\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"when compared to phenytoin and valproate,[6]\",\"explanation\":\"Reference [6] is a Cochrane review specifically comparing carbamazepine to phenytoin monotherapy for epilepsy; it does not address valproate.\",\"fixedText\":\"Retain comparison to phenytoin with [6]; add separate citation for valproate comparison using the 2000 Cochrane review on carbamazepine versus valproate monotherapy.\",\"evidenceSource\":\"[6]\"},{\"criticality\":\"Critical\",\"issueType\":\"Timeliness/Currency\",\"problematicText\":\"As of 2014, a controlled release formulation was available for which there is tentative evidence showing fewer side effects and unclear evidence with regard to whether there is a difference in efficacy.[19]\",\"explanation\":\"The cited Cochrane review [19] was published in December 2016, making the \\\"as of 2014\\\" date inaccurate and outdated relative to the source of the evidence. No newer reviews contradict the findings as of 2025.\",\"fixedText\":\"Update phrasing to reflect the 2016 review date and current availability, e.g., \\\"A controlled-release formulation is available; a 2016 Cochrane review found tentative evidence of fewer side effects but no clear difference in efficacy.[19]\\\"\",\"evidenceSource\":\"[19]\"},{\"criticality\":\"Critical\",\"issueType\":\"Scope/Applicability Misstatement\",\"problematicText\":\"partial seizures\",\"explanation\":\"The FDA indication, per the product label, specifically covers \\\"partial seizures with complex symptomatology (psychomotor, temporal lobe),\\\" not all types of partial (focal) seizures.\",\"fixedText\":\"Specify as \\\"complex partial seizures (psychomotor, temporal lobe)\\\" to match the FDA label precisely.\",\"evidenceSource\":\"[](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8d409411-aa9f-4f3a-a52c-fbcb0c3ec053)\"},{\"criticality\":\"Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"In the United States, carbamazepine is indicated for the treatment of epilepsy (including partial seizures, generalized tonic-clonic seizures and mixed seizures), and trigeminal neuralgia.[3][17]\",\"explanation\":\"The FDA label also notes beneficial results in glossopharyngeal neuralgia, which is an established indication omitted here, creating a knowledge gap in the scope of approved uses.\",\"fixedText\":\"Add \\\"and glossopharyngeal neuralgia\\\" to the list of indications, citing the FDA label.\",\"evidenceSource\":\"[](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8d409411-aa9f-4f3a-a52c-fbcb0c3ec053)\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"increased risks of suicide[21]\",\"explanation\":\"Reference [21] discusses neurostimulation for chronic migraine and cluster headache, unrelated to carbamazepine or suicide risk. This misattributes the claim, potentially misleading on evidence for a serious warning.\",\"fixedText\":\"Replace citation [21] with [3], as the Tegretol label confirms the risk as a class effect for AEDs.\",\"evidenceSource\":\"[3] (DailyMed Tegretol label, which includes FDA black box warning on suicidal behavior and ideation for antiepileptic drugs including carbamazepine)\"},{\"criticality\":\"Critical\",\"issueType\":\"Scope/Applicability Misstatement\",\"problematicText\":\"In the US, the label for carbamazepine contains warnings concerning: [full bullet list including Pancreatitis, Hepatitis, Dizziness, Bone marrow suppression, Stevensâ€“Johnson syndrome]\",\"explanation\":\"The introductory phrase claims these are \\\"warnings\\\" from the US label, but the FDA label distinguishes boxed warnings/precautions (e.g., hematologic, dermatologic/SJS-TEN, suicidal, hyponatremia, fetal risks) from postmarketing adverse reactions (e.g., pancreatitis, hepatitis) and common side effects (e.g., dizziness). Bone marrow suppression overlaps with hematologic warning but is redundantly listed. Misstating adverse reactions as warnings could mislead on severity and monitoring requirements per FDA standards.\",\"fixedText\":\"Restructure the opening list to cover only FDA boxed warnings and key precautions with accurate sourcing. Relocate pancreatitis, hepatitis, and dizziness to the common or less common adverse effects paragraphs, as they are not warnings. Integrate bone marrow suppression into the hematologic bullet. Cite [3] for SJS as a warning.\",\"evidenceSource\":\"FDA label for CARBATROL (carbamazepine) extended-release capsules (approved 2023): https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/020712s038lbl.pdf (sections 5 Warnings and Precautions, 6.3 Postmarketing Experience)\"},{\"criticality\":\"Critical\",\"issueType\":\"Timeliness/Currency\",\"problematicText\":\"propoxyphene\",\"explanation\":\"Propoxyphene (also known as dextropropoxyphene) was voluntarily withdrawn from the US market in November 2010 by the FDA due to serious cardiac risks, including QT prolongation and arrhythmias. Listing it as an example of a drug interacting with carbamazepine implies ongoing clinical relevance, which could mislead healthcare providers or patients regarding current risks.\",\"fixedText\":\"Remove \\\"propoxyphene\\\" from the list of drugs that increase carbamazepine levels.\",\"evidenceSource\":\"[](https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-recommends-against-continued-use-propoxyphene)\"},{\"criticality\":\"Critical\",\"issueType\":\"Scope/Applicability Misstatement\",\"problematicText\":\"calcium channel blockers\",\"explanation\":\"The statement implies all calcium channel blockers increase carbamazepine levels, but this is only true for CYP3A4 inhibitors like verapamil and diltiazem (non-dihydropyridines). Dihydropyridines like amlodipine have their levels decreased by carbamazepine due to induction of CYP3A4, potentially leading to incorrect assumptions about interaction direction and risks.\",\"fixedText\":\"Revise to \\\"certain calcium channel blockers (e.g., verapamil and diltiazem)\\\" to accurately reflect the scope.\",\"evidenceSource\":\"[](https://pubmed.ncbi.nlm.nih.gov/2027492/)\"},{\"criticality\":\"Critical\",\"issueType\":\"Mechanism/Specification Error\",\"problematicText\":\"Carbamazepine itself is not pharmacologically active. It is activated, mainly by CYP3A4, to carbamazepine-10,11-epoxide, which is solely responsible for the drug's anticonvulsant effects.\",\"explanation\":\"Carbamazepine (parent drug) is pharmacologically active with anticonvulsant effects via sodium channel blockade. The epoxide metabolite has comparable activity but does not solely account for effects; both contribute.\",\"fixedText\":\"Replace with: Carbamazepine is pharmacologically active and is mainly metabolized by CYP3A4 to the active metabolite carbamazepine-10,11-epoxide, which has comparable anticonvulsant activity.\",\"evidenceSource\":\"[](https://emedicine.medscape.com/article/2089796-overview)\"},{\"criticality\":\"Critical\",\"issueType\":\"Quantitative/Units Error\",\"problematicText\":\"In the circulation, carbamazepine itself comprises 20 to 30% of total residues. The remainder is in the form of metabolites\",\"explanation\":\"In plasma, the parent carbamazepine constitutes approximately 80-85% of the active compounds, with the epoxide metabolite at 15-20%; other metabolites have low plasma levels. The stated percentage reverses this, misstating distribution.\",\"fixedText\":\"Revise to: In plasma, carbamazepine constitutes the majority (about 80-85%) of circulating active forms, with the epoxide metabolite comprising 15-20%.\",\"evidenceSource\":\"[](https://emedicine.medscape.com/article/2089796-overview)\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"It was first marketed as a drug to treat epilepsy in Switzerland in 1963 under the brand name Tegretol; its use for trigeminal neuralgia (formerly known as tic douloureux) was introduced at the same time.\",\"explanation\":\"The claim states that use for trigeminal neuralgia was introduced in 1963, the same time as for epilepsy, but reliable sources indicate it was first marketed for trigeminal neuralgia in 1962. This mismatches the cited reference [43] and creates an internal contradiction with the article introduction, which states first marketed in 1962.\",\"fixedText\":\"Correct the introduction of use for trigeminal neuralgia to 1962, and clarify that the first marketing was for trigeminal neuralgia in 1962, with epilepsy approval following in 1963.\",\"evidenceSource\":\"[](https://onlinelibrary.wiley.com/doi/10.1111/j.1528-1167.2009.02042.x)\"},{\"criticality\":\"Critical\",\"issueType\":\"Internal Contradiction\",\"problematicText\":\"its use for trigeminal neuralgia (formerly known as tic douloureux) was introduced at the same time.[43]\",\"explanation\":\"The section implies the drug's use for trigeminal neuralgia began in 1963, contradicting the article's introduction stating first marketed in 1962 and multiple sources confirming 1962 for trigeminal neuralgia.\",\"fixedText\":\"Adjust to reflect 1962 for trigeminal neuralgia and 1963 for epilepsy to resolve contradiction.\",\"evidenceSource\":\"[9] and [](https://www.ilae.org/files/ilaeGuideline/ILAE-Carbamazepine-monograph-2009.pdf)\"},{\"criticality\":\"Critical\",\"issueType\":\"Source/Citation Mismatch\",\"problematicText\":\"in streams receiving treated wastewater.[47]\",\"explanation\":\"Reference 47 (Posselt et al., 2018, PMID 30350841) focuses on polar organic micropollutants in hyporheic zones but does not mention carbamazepine or its detection in streams receiving treated wastewater, as confirmed by the abstract and related searches.\",\"fixedText\":\"Remove the citation [47] and the unsupported phrase \\\"and in streams receiving treated wastewater\\\" to avoid misleading attribution. Retain the claim about effluent supported by [46].\",\"evidenceSource\":\"[47] PubMed abstract https://pubmed.ncbi.nlm.nih.gov/30350841/\"},{\"criticality\":\"Critical\",\"issueType\":\"Timeliness/Currency\",\"problematicText\":\"Taking into account only studies that used concentrations commonly found in the environment, a 2014 review concluded that \\\"the accumulation of carbamazepine into plants grown in soil amended with biosolids poses a de minimis risk to human health according to the approach.\\\"[46]: 227\",\"explanation\":\"The cited review is from a 2015 paper referencing pre-2015 studies; as of 2025, more recent research (e.g., 2023-2025 studies) confirms ongoing persistence of carbamazepine in surface waters (up to 0.1 Î¼g/L) and low removal rates (\u0026lt;60% in activated sludge), but no major updates contradict the de minimis human health risk via plant uptake. However, lacks currency for environmental persistence claims.\",\"fixedText\":\"Add a sentence noting recent confirmations of environmental persistence, citing a 2025 source, to update without altering the core conclusion.\",\"evidenceSource\":\"Web search results: Su et al. (2025) in Chemosphere; NPJ Clean Water (2025) on removal rates.\"},{\"criticality\":\"Non-Critical\",\"issueType\":\"Missing Information\",\"problematicText\":\"[No specific text; overall section]\",\"explanation\":\"Section lacks mention of ecotoxicological impacts beyond human health via plants, such as effects on aquatic organisms (e.g., bioaccumulation in fish or inhibition of algae growth), which are documented in recent studies up to 2025.\",\"fixedText\":\"Add a brief note on potential ecological risks if expanding, but since not critical to human-focused conclusion, optional for rewrite.\",\"evidenceSource\":\"Recent studies from web search (2020-2025) on emerging contaminants including carbamazepine.\"},{\"criticality\":\"Missing Information\",\"issueType\":\"Missing Information\",\"problematicText\":\"The section is empty.\",\"explanation\":\"The Research section provides no coverage of ongoing or emerging research on carbamazepine, such as developments in photopharmacology for targeted delivery or recent pharmacokinetic and toxicity studies, which are relevant to understanding future applications and improvements in safety/efficacy. This gap leaves the article incomplete for a drug with active research as of 2025.\",\"fixedText\":\"Add a paragraph summarizing key recent research areas, including photoswitchable analogues and other 2024-2025 studies on interactions and maternal exposure, with citations to peer-reviewed sources.\",\"evidenceSource\":\"[14]; [](https://doi.org/10.1002/anie.202403636); [](https://pubs.acs.org/doi/10.1021/acsomega.5c04235); [](https://pmc.ncbi.nlm.nih.gov/articles/PMC11823298/)\"}],\"slug\":\"Carbamazepine\",\"title\":\"Carbamazepine\",\"content\":\"$1f\",\"description\":\"Carbamazepine\\n\\nCarbamazepine , sold under the brand name Tegretol among others, is an anticonvulsant medication used in the treatment of epilepsy and neuropathic pain.[3][1] It is used as an...\",\"metadata\":{\"categories\":[\"Tegretol\",\"CBZ\",\"Carbatrol\",\"Equetro\"],\"lastModified\":\"1761553239\",\"contentLength\":\"18419\",\"version\":\"1.0\",\"lastEditor\":\"system\",\"language\":\"en\",\"isRedirect\":false,\"redirectTarget\":\"\",\"isWithheld\":false},\"stats\":{\"totalViews\":\"236846\",\"recentViews\":\"236846\",\"dailyAvgViews\":7894.86669921875,\"qualityScore\":1,\"lastViewed\":\"1761886115\"},\"linkedPages\":null},\"found\":true},\"dataUpdateCount\":1,\"dataUpdatedAt\":1761886115568,\"error\":null,\"errorUpdateCount\":0,\"errorUpdatedAt\":0,\"fetchFailureCount\":0,\"fetchFailureReason\":null,\"fetchMeta\":null,\"isInvalidated\":false,\"status\":\"success\",\"fetchStatus\":\"idle\"},\"queryKey\":[\"page\",\"Carbamazepine\"],\"queryHash\":\"[\\\"page\\\",\\\"Carbamazepine\\\"]\"}]},\"children\":\"$L20\"}]\n"])</script><script nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4">self.__next_f.push([1,"c:{\"metadata\":[[\"$\",\"title\",\"0\",{\"children\":\"Carbamazepine\"}],[\"$\",\"meta\",\"1\",{\"name\":\"description\",\"content\":\"Carbamazepine , sold under the brand name Tegretol among others, is an anticonvulsant medication used in the treatment of epilepsy and neuropathic pain.[3][1] It is used as an adjunctive treatment in schizophrenia along with other medications and as a second-line agent in bipolar disorder.[1][15][16] Carbamazepine appears to work as well as phenytoin and valproate for focal and generalized seizures.6 It is not effective for absence or myoclonic seizures.[1] Carbamazepine was discovered in 1953...\"}],[\"$\",\"meta\",\"2\",{\"name\":\"author\",\"content\":\"system\"}],[\"$\",\"link\",\"3\",{\"rel\":\"manifest\",\"href\":\"/manifest.webmanifest\",\"crossOrigin\":\"$undefined\"}],[\"$\",\"meta\",\"4\",{\"name\":\"keywords\",\"content\":\"Tegretol, CBZ, Carbatrol, Equetro\"}],[\"$\",\"meta\",\"5\",{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",\"6\",{\"name\":\"googlebot\",\"content\":\"index, follow, max-snippet:-1\"}],[\"$\",\"link\",\"7\",{\"rel\":\"canonical\",\"href\":\"https://grokipedia.com/page/Carbamazepine\"}],[\"$\",\"meta\",\"8\",{\"property\":\"og:title\",\"content\":\"Carbamazepine\"}],[\"$\",\"meta\",\"9\",{\"property\":\"og:description\",\"content\":\"Carbamazepine , sold under the brand name Tegretol among others, is an anticonvulsant medication used in the treatment of epilepsy and neuropathic pain.[3][1] It is used as an adjunctive treatment in schizophrenia along with other medications and as a second-line agent in bipolar disorder.[1][15][16] Carbamazepine appears to work as well as phenytoin and valproate for focal and generalized seizures.6 It is not effective for absence or myoclonic seizures.[1] Carbamazepine was discovered in 1953...\"}],[\"$\",\"meta\",\"10\",{\"property\":\"og:url\",\"content\":\"https://grokipedia.com/page/Carbamazepine\"}],[\"$\",\"meta\",\"11\",{\"property\":\"og:site_name\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",\"12\",{\"property\":\"og:locale\",\"content\":\"en\"}],[\"$\",\"meta\",\"13\",{\"property\":\"og:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"meta\",\"14\",{\"property\":\"og:image:width\",\"content\":\"512\"}],[\"$\",\"meta\",\"15\",{\"property\":\"og:image:height\",\"content\":\"512\"}],[\"$\",\"meta\",\"16\",{\"property\":\"og:image:alt\",\"content\":\"Carbamazepine\"}],[\"$\",\"meta\",\"17\",{\"property\":\"og:type\",\"content\":\"article\"}],[\"$\",\"meta\",\"18\",{\"property\":\"article:modified_time\",\"content\":\"1970-01-21T09:19:13.239Z\"}],[\"$\",\"meta\",\"19\",{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",\"20\",{\"name\":\"twitter:creator\",\"content\":\"@Grokipedia\"}],[\"$\",\"meta\",\"21\",{\"name\":\"twitter:title\",\"content\":\"Carbamazepine\"}],[\"$\",\"meta\",\"22\",{\"name\":\"twitter:description\",\"content\":\"Carbamazepine , sold under the brand name Tegretol among others, is an anticonvulsant medication used in the treatment of epilepsy and neuropathic pain.[3][1] It is used as an adjunctive treatment in schizophrenia along with other medications and as a second-line agent in bipolar disorder.[1][15][16] Carbamazepine appears to work as well as phenytoin and valproate for focal and generalized seizures.6 It is not effective for absence or myoclonic seizures.[1] Carbamazepine was discovered in 1953...\"}],[\"$\",\"meta\",\"23\",{\"name\":\"twitter:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"link\",\"24\",{\"rel\":\"icon\",\"href\":\"/favicon.ico\",\"type\":\"image/x-icon\",\"sizes\":\"16x16\"}],[\"$\",\"$L21\",\"25\",{}]],\"error\":null,\"digest\":\"$undefined\"}\n"])</script><script nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4">self.__next_f.push([1,"11:\"$c:metadata\"\n"])</script><script nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4">self.__next_f.push([1,"22:I[61172,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"PageEditorProvider\"]\n"])</script><script nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4">self.__next_f.push([1,"23:I[63493,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"default\"]\n"])</script><script nonce="YmI5M2NhMTItMTVkMC00ZTQ5LWEzYmYtYTc4MzJiMTYxMTk4">self.__next_f.push([1,"20:[\"$\",\"$L22\",null,{\"children\":[\"$\",\"$L23\",null,{\"slug\":\"Carbamazepine\"}]}]\n"])</script></body></html>